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ABSTRACT 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
A case control study to identify the precipitating factors for recurrent Myocardial Infarction at 
selected setting, Chennai. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
     One in every two patient with first episode of  Acute Coronary Syndrome (ACS) develops 
recurrent ischemic event in their life time. Although recent advances in reperfusion treatment, 
which was considered  as one of the major breakthrough in the field of cardiovascular medicine 
has contributed to better short-term outcomes,it has become crucial to restore cardiac function 
for better long term outcomes. By 2030, it is expected that the incidence of MI will increase  by 
16.6%  compared with 2010 making skill full care and evidence based preventative measures key 
among efforts to reduce the increasing prevalence of MI and its recurrence.(Advances in MI 
management, June 2013) 
 
 
Aim and objective: To identify the significant precipitating factors for recurrent myocardial 
infarction(MI) at selected setting, Chennai. Methodology:  A non-experimental design, 
retrospective approach was chosen to identify the precipitating factors for recurrent MI at selected 
setting, Chennai. Patients with incident and recurrent MI who fulfilled the inclusive criteria were 
selected as samples using non-probability purposive sampling technique. Demographic details and 
precipitating factors were assessed using structured interview schedule and record reviews. 
Result: The study findings identified significant precipitating factors for recurrent MI such as 
episodes of anginal pain after thrombolysis, Non ST elevation MI, Non-Transmural infarction, 
central obesity, chronicity of  Diabetes Mellitus(DM), history of Cerebro Vascular Accident (CVA), 
family history of dyslipidemia, interrupted sleep pattern, night shift, duration of sleep and non-
vegetarian diet. Conclusion: The research investigator identified significant precipitating factors for 
recurrent MI and developed a criteria to assess MI clients for creating awareness among MI 
survivors about the importance of  secondary prevention. 
Keywords: incident MI, recurrent MI, precipitating factors, secondary prevention, 
  
OBJECTIVES 
 To associate the selected factors such as clinical prognostic factors, genetic factors, life 
style factors and dietary factors between the case and control group. 
 
 To identify the significant precipitating factors for recurrent Myocardial Infarction among 
the group. 
 
METHODOLOGY 
Research Design 
Non experimental research design, retrospective approach case control  study. 
 
Variables 
Research variable 
 Precipitating factors for recurrent Myocardial Infarction such as clinical prognostic 
factor,genetic factor, lifestyle factor and dietary factor. 
 
Setting 
 Case group & Control group ± Cardiac OPD in Frontier Life Line hospital, Mogappair, 
Chennai. 
 
Population 
Target population 
The target population consisted of all patients with medical history of  recurrent MI as 
case group and incident MI as control group. 
 
Accessible population 
All patients attending 23'¶V RI )URQWLHU /LIH /LQH KRVSLWDl with medical history of 
recurrent MI  as cases and incident MI as controls. 
 
  
Sampling  
 Non-probability purposive sampling technique was used to select 117 patients as samples 
who fulfilled the inclusive criteria as samples from Frontier Life Line hospital  
 
Measurement and tools 
 The precipitating factors for recurrent MI was identified using structured interview 
schedule & record reviews. 
 
RESULTS 
 The study findings revealed that there is significant association between case and control 
group with various factors predisposing to develop recurrent MI. The identified precipitating 
factors included 
 Clinical Variability factors -  chronicity of DM and HT, episodes of angina pain, 
NSTEMI, non-transmural infarction, body mass index, central obesity and co-morbidity 
(respiratory, renal disease & CVA) 
 Life Style factors ± smoking & its cessation, alcohol intake, duration of sleep and sleep 
pattern, working hours  and night shift 
 Genetic factors ± Paternal &maternal history of dyslipidemia, paternal, maternal and 
sibling history of HT and paternal history of heart disease. 
 Dietary factors ± Non-vegetarians, consumption of  non ±veg foods like chicken. Mutton 
& fish 
The factors identified to be protective against risk of recurrent MI includes, 
 Rehabilitation programme 
 Habit of doing exercise and longer duration of exercise 
 Intake of green leafy vegetables 
 
 
 
 
DISCUSSION 
 The findings revealed the precipitating and protective factors of recurrent MI which aids 
in developing assessment criteria  for MI clients. 
 
Implication for clinical practice 
 Nurses working in health care units should be aware of these precipitating factors in 
assessing MI clients for risk of developing recurrent events. Nurse educators/administrators 
should arrange  health education sessions in hospitals and community health center to create 
awareness and educate public about the importance of secondary prevention of MI.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
CHAPTER 1 
INTRODUCTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INTRODUCTION 
 
Non Communicable Diseases (NCDs) are chronic diseases with generally of long 
duration and slow progression. The four top most NCDs are cardiovascular diseases (like heart 
attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructed pulmonary 
disease and asthma) and diabetes. Low and Middle-Income Countries (LMIC) are already 
affected, where nearly three quarters of NCD deaths- 28 million occur every year. 
CardioVascular Diseases (CVD) account for most NCD deaths, or 17.5 million people annually, 
followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). 
These 4 groups of diseases account for 82% of all NCD deaths. Tobacco use, physical inactivity, 
the harmful use of alcohol and unhealthy diets all increase the risk of dying from a NCD, of 
these CVDs rank the highest. (WHO Fact Sheet, 2012) 
 
      Heart and blood vessel disease also called cardio vascular disease includes numerous 
problems, many of which are associated to a process called atherosclerosis. Atherosclerosis is a 
condition that develops when a substance called plaque builds up in the walls of the arteries. This 
buildup narrows the arteries, making it harder for blood to flow through and eventually grow or 
rupture to occlude the arteries. When atherosclerosis occurs in coronary arteries it is termed as 
Coronary Artery Disease (CAD). The most common types of cardiovascular diseases are 
coronary artery disease, congestive heart failure, cardiomyopathies, arrhythmias, myocardial 
infarction, valvular disease and peripheral vascular disease. 
 
1.1 BACKGROUND OF THE  STUDY 
      For more than a decade, CVD has become the distinct cause of death worldwide and 17.3 
million deaths were reported (World Heart Federation, 2008). According to the Global Burden 
of Disease estimates 68% of the 751 million years Living With Disability (YLD) worldwide is 
attributable to NCDs, and 84% of this burden of NCD disability arises in LMICs. CVDs are 
responsible for 151 million DALYs, of which 62  million are due to coronary heart 
disease.(Cardiovascular Disease Prevention and Control ± Global Atlas WHO 2011). 
     Cardiovascular disease continues to cause as large proportion of deaths and disability in 
and places a substantial burden on the health care systems and economies. The overall picture, 
and the distribution of the burden, continues to evolve in LMIC. There have been major 
improvements in recent years on many measures of cardiovascular disease; however, these 
improvements have not been universal, and substantial inequalities persist. 
 
Table 1.1.1 Number and percentage of deaths from cardiovascular diseases world wide 
Gender & age 
CVD (Total) CAD (Total) 
Other 
CVD(Total) 
No. % No . % No. % 
Male: Total deaths (all ages) 18,62,004 42 8,76,478 20 5,53.569 12 
Premature deaths - before age 75 9,46,280 37 4,77,833 18 2,64,833 10 
Premature deaths - before age 65 5,08,228 31 2,53,734 16 1,58,939 10 
Females Total deaths (all ages) 22,22,657 51 9,05,706 21 6,85.312 16 
Premature deaths - before age 75 5,44,769 38 2,37,673 16 1,49,314 10 
Premature deaths - before age 65 2,02,175 27 77,477 10 69,776 9 
Total deaths (all ages) 40,84,661 46 17,82,184 20 12,38,881 14 
Premature deaths - before age 75 14,91,049 37 7,15,506 18 4,14,147 10 
Premature deaths - before age 65 7,10,403 30 3,31,211 14 2,28,715 10 
(Source: WHO mortality database, 2013) 
      According to WHO report, the current age standardized CVD mortality rates among 
males and Females in India (per 100,000) are 363-443 and 181-281 respectively 
(Cardiovascular Disease Prevention and Control, WHO 2011). In Tami Nadu, the mortality 
rate was high in the country due to CVD that is 360-430 per lakh population. The state suffers 
from DM, HT and overweight with variable percentage of population. . (The Hindu, 2013) 
 
 
 
      Another report states that mortality rate of about 24 percent in rural Tamil Nadu are due 
to CAD (Centre for Technologies in Public Health, 2011). The prevalence of CAD according 
to the Chennai Urban Population Study was 11%. This was a drastic increase from 2% in 1970. 
(Viswanathan. M et al 2001). 
 
       CAD mortality and risk factor surveillance in India is very primitive and no organized 
system exists in rural as well as urban populations. Acute Coronary Syndrome (ACS) is the most 
common reason for hospitalization. Myocardial Infarction (MI) which can be ST segment 
Elevation Myocardial Infarction (STEMI) or Non ST segment Elevation Myocardial Infarction 
(NSTEMI) is the most common cause of morbidity and mortality worldwide. In US about 1.1 
million cases occur every year with about 30% mortality and more than 50% of deaths occuring 
on the way to the hospital. In India, 31.7% of deaths are due to MI (Shraddha Chauhan and 
Bani Tamber Aeri, 2013). 
 
Table 1.1.2:  Forecasting the number of cases (males and females) of Coronary Heart 
Disease (CHD) in India. 
 
Year/ 
area 
2015 
20 - 29yrs 30 - 39yrs 40 - 49yrs 50 - 59yrs 60 -69yrs Total 
Urban  8,167,924 7,927,846 8,493,463 6,156,089 5,346,975 36,092,297 
Rural  2,324,087 4,523,697 5,816,588 6,852,050 5,913,624 25,430,046 
Total  10,492,011 12,451,542 14,310,051 13,008,140 11,260,599 61,522,343 
(Source: International Journal of Scientific and Research Publications, October 2013) 
      Most MI occurs in people over 50 yrs and become more common with increasing age. 
Sometimes younger people are also affected. An MI is more common for men than women. MI 
can also occur in people who have a past history of heart disease such as angina. It also happen 
³RXWRIEOXH´LQSHRSOHRIDOOFDVHVDQGGHaths. 
 
 
 
Table 1.1.3: ACS in INDIA 
 
Source 
ACS Mean age 
Yrs STEMI NSTEMI 
CREATE (Treatment & outcomes of ACS in 
India) 
61% 39% 57 
Global Registry of Acute Coronary Syndromes 30 ± 40% 60-70% 64-69 
European Heart Surveys 42% 51% 63 
US National Registry of myocardial infarction --- ---- 68 
(Source: Indian ACS registry ± CREATE, Xavier et al 2011) 
 
 
Figure 1.1.1 Prevalence of MI by age and gender 
(Source: National nutrition and health examination survey 2009-2012, American Heart 
Association) 
 
      Risk factors are conditions or habits that increase the risk of acquiring a disease 
condition. Similarly CAD risk factors increase the risk of MI. These risk factors also increase the 
chance that existing CHD may worsen. The distribution of risk factors varied significantly 
between women and men controls. 
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Table 1.1.4:  Risk factor burden related to MI between men and women 
Risk factors 
Odds ratio 
Male Female 
Apo lipoprotein B/A1 ratio 3.30 2.87 
Smoking  2.86 3.04 
Hypertension  2.95 2.32 
Diabetes mellitus 4.26 2.67 
Abdominal obesity 2.26 2.24 
Psychosocial  3.49 2.58 
Physical inactivity 2.07 1.30 
Alcohol intake 2.42 1.13 
High risk diet 1.78 1.68 
(Source: European Heart Journal, 2009) 
 
      Patients with an ACS continue to represent a major health concern. The rate of ACS 
recurrence in this group remains relatively high. These patients with a recurrent ACS have worse 
outcomes, however, the timing of these adverse outcomes and  the contributing factors, remain 
unexplored. 
 
      Recent clinical studies suggest a residual rate of recurrent events of approximately 10% 
per annum after an initial ACS event, with most of these events occurring after discharge from 
hospital. (American Heart Association 2013). 
 
1.2 SIGNIFICANCE AND NEED FOR THE STUDY 
      There are 32.4 million myocardial infarctions worldwide every year. Patients with 
previous myocardial infarction (MI) are the highest risk group for further coronary events. 
Survivors of MI are at increased risk of recurrent infarctions and have an annual death rate of 5% 
- six times that in people of the same age who do not have CHD. 
(Source: Prevention of Recurrences of Myocardial Infarction and StrokE (PREMISE) 
country project, 2005) 
 
       The WHO MONICA (Multinational MONItoring of Trends and Determinants in 
CArdiovascular Disease) Study, monitored trends in CHD across 38 populations in 21 countries 
over 10 years. Data from this study indicate that secondary prevention and changes in coronary 
care are strongly linked with declining coronary end-points. 
 
      Secondary prevention is detecting the disease in the early stages and implementing 
intervention before symptoms develops. These intervention are very much cost effective and its 
implementation at a large scale will definitely have an influence on life expectancy. Marmot 
review (2010) identified that one of the most effective ways to reduce the gaps between life 
expectancy and health outcome is secondary prevention.  
 
Secondory prevention warrants following action: 
 Appropriate coverage of vital secondary preventive interventions and procedures 
 Cost effective systematic screening 
 Control of HT, cholesterol & DM 
 Secondary prevention as a part of broader strategy for public health 
 Community & voluntary sector gaps to render services for patients who are not 
covered by mainstream health services. 
 
    Secondary prevention of CAD by widespread risk factor modification reduces 
mortality, decreases subsequent cardiac events, and it also improves the quality of life. Risk 
factor modification plays a vital role in secondary prevention.. Therapeutic lifestyle changes 
includes, 
 
 Physical activity: 
An important component of secondary prevention of CAD is regular physical activity. 
It helps in  increasing the exercise capacity and  in treating co morbid risk factors, thereby  
improves quality of life. Compared with usual care exercise-based cardiac rehabilitation has 
shown a  reduce  in recurrent event  and cardiac mortality  
 
 Weight and dietary management: 
The American Heart Association (AHA) recommends measuring BMI at each  visit, 
followed by a objective feedback and counseling on weight reduction strategies. Balance of 
physical activity and moderation of caloric intake helps in achieving long-term weight 
maintenance. 
 
 Tobacco Use: 
Cessation of smoking after a myocardial infarction (MI) reduce the risk of recurrence 
by at least one third, and is as beneficial as modifying other risk factors. 
 
All the above mentioned factors are universally recommended by evidence-based 
guidelines (Scott and Todd 2010) 
 
Bruce and Susan (2015) conducted a study to investigate the association between central 
fat distribution and the risk of recurrent coronary events among a cohort of female MI survivors. 
Participants included 356 women (mean ± SD age, 55 ± 8.71 years) discharged alive after an 
incident MI from hospitals in Erie and Niagara (New York) Countries between 1996 and 2004. 
Interviews and self-administered follow-up surveys were used to collect pertinent 
information.  Eighty-five women experienced a recurrent cardiovascular event. Using Cox 
proportional hazards analyses, the crude model for body mass index suggested that after incident 
MI, women had a 39% risk of a recurrent CVD event. Central fat distribution appeared to be 
better predictor  of recurrent cardiovascular events when compared with body mass index 
 
Marmor Alon., Sobel.E.Burton and Robert (2012) conducted a prospective study in 
UK to identify the factors presaging recurrent MI. Serial MB CK and myoglobin determinations 
and continuous electrocardiographic recordings was obtained from 200 consecutive patients with 
acute MI for 14 days, and serial radioventriculograms were obtained in selected patients Logistic 
regression analysis indicated that obese women with initial subendocardial infarction and 
repeated episodes of prolonged chest pain had a high probability rate (60 percent) of recurrence 
in contrast to the low probability (2 percent) in patients without these features. Thus early 
recurrent infarction is frequent after subendocardial infarction and is associated with a marked 
increase in mortality. These results suggest that patients with subendocardial infarction are at 
particularly high risk for recurrent infarction and that patients with this type of infarction require 
vigorous monitoring and prolonged surveillance. 
 
Cheng ka-on (2013) conducted a meta analysis of randomized control trials in China on 
the effect of early patient education on recurrent myocardial infarction . Patients who received 
early patient education showed a reduction of recurrent MI risk by 3% to 100%; the summarized 
relative risk of the interventional group was 0.80 compared with the control group. This means 
there resulted a 20% reduction in recurrent MI. Early patient education was shown to have a 
positive effect on the prevention of recurrent MI in this meta-analysis. 
 
     Vinay and Prasanna Lakshmi (2014) conducted a hospital-based case-control 
study of patients with a first MI in Mangalore, India, primarily to assess the relative 
importance of the risk factors for recurrent ischemic events. A total of 100 cases and 100 age 
and sex-matched controls were taken into this prospective case-control study from Intensive 
Coronary Care Unit. Prevalence of the following risk factors for MI such as age, sex, diet, 
smoking, alcohol consumption, history of hypertension, history of diabetes mellitus, and lipid 
profile were studied. Patient data were extracted from the medical records department and by 
interview. The result suggested that the most important predictor was high low-density 
lipoprotein, history of hypertension and overt diabetes mellitus. 
 
Tahereh et al (2011), conducted a retrospective study among 1283 MI patients who 
were hospitalized in Tehran Heart Center from March 2005 to March 2006 were followed up 
in March 2008. Demographic, clinical and Socio economic status data were collected from 
case records and by telephone interviews. Multiple logistic regression analysis was performed 
to estimate the predictive effect of socioeconomic factors on outcome. The result from all 664 
patients studied: Of these, 500 patients were alive and 164 were dead due to MI. The results of 
regression analysis showed that in addition to treatment, having diabetes  or hyperlipidemia, 
socioeconomic variables including living area in square per person, unemployment  and 
education were the most significant contributing factors to increased recurrent event after 
incident MI. 
 7KH ILQGLQJV IURP WKHDERYHVWXGLHVDQG LQYHVWLJDWRU¶VH[SHULHQFH LQ KDQGOLQJ SDWLHQWV
who had recurrent MI in cardiac ward and intensive care unit, made the researcher to realize the 
importance of  secondary prevention. The researcher understood the need to develop an 
assessment criteria for MI patients to identify their risk of developing recurrent events. By 
assessing the risk, the nurses in the  hospital and community areas will be able to create 
awareness about secondary prevention which in turn can reduce further complication and 
mortality among MI survivors. 
 
1.3 STATEMENT OF THE PROBLEM 
A Case Control study to identify the precipitating factors for recurrent Myocardial 
Infarction in selected setting, Chennai. 
 
1.4 OBJECTIVES 
1. To associate the selected factors such as clinical prognostic factors, genetic factors, life 
style factors and dietary factors between the case and control group. 
2. To identify the significant precipitating factors for recurrent Myocardial Infarction among 
the group. 
 
1.5 OPERATIONAL DEFINITIONS 
1.5.1 Case 
It refers to individuals with medical history of recurrent (repeated episodes) MI after 28 
days of incident MI 
 
1.5.2 Control 
It refers to individuals with medical history of incident (first episode) of MI without 
recurrence for atleast one year.  
 
1.5.3 Precipitating Factors 
It refers to characteristics or conditions that increase the possibility for recurrence of MI 
using a structured interview schedule. The factors are 
 1.5.3.1 Clinical prognostic factors: 
The factors include body mass index, central obesity, revascularization procedure, type 
and location of infarction, episodes of anginal pain after thrombolysis, Diabetes Mellitus, 
Hypertension, history of co-morbid illness, dyslipidemia, compliance to drug therapy and 
participation in rehabilitation program. 
 
1.5.3.2 Genetic factors 
The factors include family history of heart disease, hypertension, Diabetes Mellitus and 
Dyslipidemia. 
 
1.5.3.3 Life style factors         
The factors include habit of smoking and alcohol, nature of work, sleep pattern and 
exercise pattern. 
 
1.5.3.4 Dietary factors 
The factors include type of food intake, frequency and type of non-vegetarian foods, salt 
and sugar intake, consumption of fruits and vegetables, cooking style, intake of fried and 
preserved foods. 
 
1.5.4 Myocardial Infarction 
Injury and death of  heart muscles caused by obstruction of blood flow due to blood clot 
or fat deposition leading to impaired cardiac functioning. 
 
1.6 RESEARCH HYPOTHESES 
RH1: There is a significant association of selected factors such as clinical prognostic, genetic, life 
style and dietary factors between the case and control group. 
RH2: There are significant precipitating factors for recurrent Myocardial Infarction among case 
and control group. 
 
 
1.7 DELIMITATIONS  
The study was delimited to a period of four weeks 
 
1.8 CONCEPTUAL FRAMEWORK 
A conceptual framework or model refers to interrelated concepts gathered together in a 
rational scheme by virtue of their relevance to a common theme that propose a framework for 
conducting research. 
 
The investigator adopted the conceptual framework based on Betty Neumans System 
Model, which was used to identify the precipitating factors for recurrent MI. The dynamic 
interaction between person and their environment was clearly depicted in the model  
 
Basic Core Structure 
Determinants include  physiological, developmental, spiritual factors and socio-cultural 
factors. Which are distinct to each individual were explained under the basic core structure.  This 
component of the model also discusses the response to the stressors by the individual and aids 
them to cope up with these stressors. 
 The core structure of the model represent men and women who are medically diagnosed 
with incident & recurrent MI of age between 30-70 years for control and case group respectively. 
 
Stressors 
6WUHVVRUV DUH IDFWRUV RU D VWLPXOXV WKDW GLVUXSWV UHVSRQVH RU PDQLSXODWH WKH ERG\¶V
equilibrium. 
 
Both groups may or may not be exposed to various risk factors of recurrent MI like 
diabetes mellitus, hypertension, central obesity, non ST elevation MI(NSTEMI), non transmural 
infarction, smoking, alcoholism, co-morbid illness, angina pain after thrombolysis and family 
history of heart disease and dyslipidemia. 
 
 
 
Line of resistance 
Line of resistance is a broken line, which acts only when the normal line of defense could 
not cope up with the stressors leading to alteration in normal health pattern.  The line of 
resistance helps to facilitate coping and overcome the stressors which affects the individual. 
 
The line of resistance of this model in case group indicates patient with all or some 
precipitating factors for recurrent MI like anginal pain after thrombolysis, NSTEMI, non 
transmural type of infarction , central obesity, co-morbid illness, etc. 
 
In control group there is an absence of all or some of these precipitating factors. 
 
Normal line of defense 
It operates in consistent with a state of wellness. It is the response of the patient when 
exposed to any stressor. The normal line of defense is considered as the essential element of 
health in the health continuum. 
 
For case group, normal line of defense is they seek health care support monthly once or 
quarterly due to their repeated episodes of MI and related management. 
 
The normal line of defense for control group involves yearly follow up care. 
 
Flexible line of defense 
)OH[LEOHOLQHRIGHIHQVHLQYROYHVWKHERG\¶VFRSLQJPHFKDQLVPZKLFKKHOSVWRRYHUFRPH
the stressors/stressful situations thereby assist in achieving a state of equilibrium in the patients 
system. 
 
In case group the patient is unable to manage the stressors and hence developed recurrent 
MI. 
 
In control group the patient, by modifying the risk factors attains a sense of stability, 
which eliminates the risk of developing recurrent MI. 
  
Degree of reaction 
The end result of stressors and coping mechanism adapted by the line of resistance is 
termed as the degree of reaction. Depending on the patients reaction towards stressors and degree 
of reaction, the results may be positive or negative. 
 
In case group, due to changes in the determinants the patient developed recurrent MI. 
   
In control group, the patient did  not develop recurrent MI. 
 
Secondary prevention 
Secondary prevention aims at eliminating the factors which have resulted in alteration in 
health. 
 
In secondary prevention the investigator recommends identification of precipitating 
factors for recurrent MI, by developing assessment criteria for MI clients. These assessment 
criteria could be used for regular screening for MI clients. 
 
Tertiary prevention 
7HUWLDU\ SUHYHQWLRQ IRFXVHV RQ UHKDELOLWDWLRQ WKXV KHOSV LQ VWUHQJWKHQLQJ SDWLHQW¶V FRUH
structure after being exposed to stressors and experiencing ill effects of it. Its central purpose is 
to prevent recurrence of MI. 
 
The investigator recommends intense secondary prevention programme to prevent further 
recurrence of MI and its complication. 
 
,W LV WKHUHIRUHHYLGHQWWKDWWKLVFRQFHSWXDO IUDPHZRUNEDVHGRQ%HWW\1HXPDQ¶V System 
model is appropriate for this study.    
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1.10 OUTLINE OF THE REPORT 
 
Chapter 1 :   Deals with the background of the study, need for the study,  
       statement of the problem, objectives, operational definitions,  
       research hypothesis, assumptions, conceptual framework and  
       delimitation of the study. 
Chapter 2 :   Contains  review of literature. 
Chapter 3 :   Presents the methodology of the study and plan for data analysis. 
Chapter 4 :   Focuses on data analysis and data interpretation. 
Chapter 5 :   Enumerates the discussion of the study 
Chapter 6 :  Gives the summary, conclusions, implications, recommendations and 
limitations. 
        The study report ends with selected references and appendices 
 
 
 
  
  
 
 
CHAPTER 2 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
Review of literature is a extensive, exhaustive and systematic examination of publications 
relevant to the research project which contributes to the new knowledge, insight and scholarship 
of the researchers. The major goal of a good review of literature is to develop a strong 
knowledge base to carry out a quality research. 
 
This review of literature was done using the key words such as incident MI, recurrent MI, 
precipitating factors for recurrent MI, protecting factors against recurrent MI, secondary 
prevention, complications of MI, clinical factors for recurrence, life style factors, genetic factors 
and dietary factors. This review was done via standard databases such as COCHRANE library, 
CINAHAL, Google Scholar, MEDLINE, PubMed, and other unpublished studies from 
dissertations. It includes cross-sectional surveys, case-control studies, cohort studies, 
longitudinal prospective studies systematic reviews, randomized controlled trials (RCTs) and 
experimental studies that assess the risk factors for recurrence of MI. Out of 63 studies identified  
from the  above databases, 43 were relevant to the research topic. Among the selected 43 studies 
7 were Indian literatures and 36 were International studies. The relevant reviews were organized 
as follows: 
 
SECTION 2.1:  Scientific reviews related to precipitating factors 
2.1.1 Scientific reviews related to clinical prognostic factors 
Time trends in incidence & fatality in various age and gender groups are of profound 
interest and analysis of these factors makes us to understand the vitality of secondary prevention. 
Sulo.G et al (2009) while examining the trends of recurrence rate, found that incidence and 
mortality due to recurrence increases greatly with age mostly among patients aged 65+ years, 
and less favourably among younger patients.. Similarly Dan Lundblad et al (2010) identified 
that the incidence of both MI and  its recurrence declined among men , whereas among women it 
showed an upward trend. 
 
Deprived socioeconomic status (SES) also put MI survivors at risk of recurrent events. 
This was studied by a series of researchers Koren.A, Steinberg.D.M, Drory.Y and Gerber.Y 
(2010) by a follow up review of first MI survivors through 2005 using a Composite Derived 
Index to assess SES. It was inferred that by  incorporating multilevel approaches & reducing 
geographic health disparities effectiveness of secondary prevention initiatives could be 
increased. 
 
Many clinical factors are known to predict the prognosis and outcome after an incident 
MI, but very few predict patients at risk of recurrence. Retrospective study done by Rurik 
Lofmark, (2011) identified 3 episodes of angina pain during hospitalization after thrombolysis 
as a risk for recurrent MI. Similar result was observed by Marmor.A et al (2010) in addition to 
other factors such as NSTEMI and Non-Transmural type of infarction as a precipitating factor 
for recurrent MI. A nationwide observation study done by Gilles Montalescot et al (2009), 
found that patients with NSTEMI appear to be undertreated after discharge from hospital. With 
other co-morbid illness, these groups  should be given similar secondary prevention therapies to 
avoid recurrent ischemic events. Some other factors related to recurrence of MI was identified by 
Saito.D, Shiraki.T, Oka.T, Kajiyama.A and Takamina.T (2007)  in an observational study 
among 808 Japanese with incident MI patients. Variables identified were transient atrial 
fibrillation, previous cerebrovascular accident and dyslipidemia. It was suggested that more 
intensive treatment and rehabilitation is needed for patients with the above risk factors. 
 
Restoring postinfarction cardiovascular function remains a big challenge in the field of 
cardiovascular disease management. Reseachers Planken Lula, Rozential Alu and Ekha Lae 
(2011) identified that revascularization procedure like intracardiac shunting and coronary 
angioplasty was effective to intracoronary thrombolysis alone. The result was supported by 
Gregg.W.Stone et al, (2011) who examined the incidence of recurrent MI after different 
reperfusion strategies. The findings showed a much lower rate of recurrence after coronary 
angioplasty when compared to rT-PA management. 
 
Although excess adiposity is known to increase the risk of CAD, its impact in patient 
with established CAD is less defined. In order to evaluate the association and its mechanism 
researcher Rea. TD, Heckbert. S.R and  Kaplan. R.C (2009) and Smith. N.L, Lemaitre. R.N. 
and Lin.D, (2010) conducted a population based inception cohort of survivors with incident MI 
after hospital discharge. The findings revealed that as BMI increases, risk of recurrent event also 
increases particularly among those who were obese. A more accurate predictor for recurrent MI 
was found to be central obesity since there is an association between central fat distribution and 
risk of recurrent MI as reported by Bruce.C and Susan.E (2012) among a cohort of MI 
survivors. These findings show that a more detailed investigation into the association of central 
obesity and management of secondary prevention is warranted. 
 
Carola.B.Giorda etal (2009) reported that metabolic disorders like DM were also found 
to have an ill effect on patients in developing recurrent cardiac events. This was identified  by 
estimating the risk of recurrent MI in diabetic patients. The findings  also insisted the need for 
aggressive treatment in secondary CAD prevention for such patients. Similar result was 
identified by Kenneth.J.Mukamal et al (2013)  in their cohort study  which states that among 
early survivors of Acute Myocardial Infarction (AMI), DM was associated with nearly two fold 
higher recurrent rate which subsequently increases mortality rate as well. The results also added 
that this magnitude of risk associated with DM was similar with that of previous MI. Chuvn et 
al (2010)  found the association of recurrent MI among insulin and non-insulin treated DM. The 
result showed that a year after MI, elderly patients with non-insulin- and insulin-treated diabetes 
mellitus had significantly greater risk for readmission for recurrent myocardial infarction than 
patients without diabetes mellitus, and risk was found to be high among insulin treated patients. 
CAD is the most lethal cardiovascular sequel of HT and  post infarction outcome was 
poor in HT patient. Agha.W.Haider et al (2009) examined the risk of antecedent HT on 
outcome after incident MI. The researcher identified that recurrence rate was higher in Stage II to 
IV HT subjects. Researchers Deaconu.A, Ismail.A, Iancivic.S and Dorobantu.M (2013) 
explained the characteristic and prognostic importance of HT patients presenting with STEMI. 
The result showed that HT is associated with increased rate of adverse events after MI and 
follow up efforts should aim in controlling BP to decrease recurrent coronary events. 
        
All the above studies identified the importance of strengthening the secondary prevention 
strategies for MI survivors. The crucial role of secondary prevention programmes in preventing 
recurrent MI was studied by so many researchers like Harbman.P, (2010) and Clark.A.M, 
Hartling.L, Vandermeer.B and McAlister.F.A, (2009) for CAD on reduction of recurrent MI 
by meta analysis. The researcher also identified a significant reduction in recurrent MI in patient 
who received secondary intervention programmes. Most of these programmes improved the 
quality of life or functional status. 
 
A descriptive cross sectional and correlational study was done by Rafael et al, (2014) to 
examine the psychological and somatic factors associated with recurrent MI by assessing patients  
for level of depression, anxiety, vital exhaustion and sleep disturbances. The researchers 
identified vital exhaustion and anxiety as a risk factor for recurrent MI. 
 
Stefano DI Bartolomeo, Massimiliano Marino, Paolo Gaustaroba, Franscesa Valent 
and Rossana De Palma, (2014)  in their self controlled case series study identified that 
adherence to recommended Beta Blocker (BB) therapy reduces the risk of recurrent MI by 20%. 
Simialarly researchers Claudio Rapezzi et al, (2015) found that poor adherence to Angiotensin 
converting enzyme inhibitors(ACE-I) or angiotensin receptor blockers(ARB) was associated 
with 20% increase in risk of recurrent MI. These studies showed that adherence to either 
prescribed  BB and ACE-I/ARB was effective against recurrent MI. But (Van der elset et al 
2011)  in their research stated that effect of combination of drugs from different classification  
proved effective against recurrent MI by 41%. 
 
2.1.2 Scientific reviews related to life style factors 
0DMRULW\RIOLIHVW\OHIDFWRUVKDYHDPDMRULPSDFWRQDSHUVRQ¶VKHDOWKHVSHFLDOO\OHDGLQJ
to deterioration in cardiovascular health. Smoking status was associated with elevated risk for 
recurrent events which was evident from the research findings of Rea TD et al, (2012) and 
Grand A, Fitchter.P and Hinet. J.F, (2010) The result indicates that among person quitting 
smoking after incident MI, the risk of recurrent MI declined to a level equal to that of non 
smokers by about 3 years after cessation. Poor prognosis and nonfatal recurrent MI events was 
seen in MI survivors with the habit of alcohol consumption. Imre Janszky, (2008) in his 
research study found a significant association that binge drinking increases the risk of recurrent 
MI by 12%. Yariy et al, (2010), conducted population based cohort study to compare the  
incidence of recurrent MI among smokers, pre MI-quitters, post MI-quitters and persistent 
smokers using a population based cohort study. The result revealed that smoking cessation either 
before or after AMI is associated with improved survival. Among persistent smokers, reducing 
intensity after AMI appears to be beneficial. 
 
Poor sleep and sleep without a restorative function are associated with poor prognosis 
after incident MI. Recurrent MI was observed by researcher  Leinweber.c, Kecklund.G, 
Akerstedt.T and Orth Gomer.K, (2008) in their research work. In addition to the findings, 
association between sleep problems and cardiac events was also explained (Stockholm female 
Coronary risk study) 
 
2.1.3 Scientific reviews related to genetic  factors 
According to CADI research foundation (Coronary Artery Disease in Asian Indians) 
risk of recurrent MI is as high as 12 fold when multiple family members has a history of heart 
disease & dyslipidemia. The risk is also significantly high if any one of the family members had 
a history of heart disease.  
 
SECTION 2.2: Scientific reviews related to secondary prevention 
2.2.1    Scientific reviews related to secondary prevention 
 According to Pantaleo Giannuzzi, et al (2008) in a multicentre randomized controlled 
trial found that continued reinforced intervention upto 3 years after rehabilitation following MI is 
effective in decreasing risk of several CV outcomes particularly recurrent MI. Krishnaraj. 
S.Rathod, Shoaib Siddique., Barron Gin, John Hogan and Sandy Gupta (2012) also found 
that comphrehensive cardiac rehabilitation programme not only provide them with risk factor 
management but also strengthen patients adherence to medication. Series of researchers Cooper 
et al (2009) identified that cardiac rehabilitation programme have been consistently shown to 
reduce mortality & recurrent ACS event. 
 
SUMMARY 
 The above literature provided scientific evidence in identifying the precipitationg factors 
for recurrent MI and also stated the importance of secondary prevention 
 
  
 
 
 
 
CHAPTER 3 
RESEARCH METHODOLOGY 
 
 
 
 
 
 
 
 
 
 
 
 
RESEARCH METHODOLOGY 
 
Research Methodology is the way to solve the research problem scientifically and  
systematically. It helps in understanding the research problem with the logic behind them. 
 
This chapter deals with the methodology adopted for the study. It includes the research 
approach, design, variables, setting, population, sample, criteria for sample selection, sample 
size, sample technique, development & description of the tool, content validity, pilot study, 
reliability of the tool, data collection procedure and plan for data analysis. 
 
3.1 RESEARCH APPROACH 
A quantitative research approach has been used for this design was chosen for this study. 
 
3.2 RESEARCH DESIGN 
A Non Experimental retrospective case control design was chosen for the study.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.2.1: Schematic representation of the Case-Control study design 
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3.3 VARIABLES 
3.3.1  Research variable: 
Precipitating factors for recurrent Myocardial Infarction such as clinical prognostic 
factors, genetic factors, lifestyle factors and dietary factors. 
 
3.3.2  Extraneous variables 
Age, gender, education, occupation and  marital status.  
 
3.4 SETTING OF THE STUDY 
The setting for the study was Frontier Life Line Hospital, Mogappair, Chennai. It is a 
renowned 120 bedded  hospital for Cardiovascular disease management. It has 6 cardiac Out 
Patient Departments (OPD) functioning from 9am to 5pm with an average of 120 patients per 
day. The OPD waiting area can accommodate 40 patients at a time.   
 
3.5 POPULATION 
3.5.1 Target population 
The target population consisted of all patients with medical history of  recurrent MI as 
case group and incident MI as control group. 
 
3.5.2 Accessible population 
All patients with medical history of recurrent MI  as cases and incident MI as controls, 
attending the  23'¶VRI)URQWLHU/LIH/LQHKRVSLWDl comprised the accessible population. 
 
3.6 SAMPLE 
The patients with incident MI and recurrent MI who satisfied the inclusive criteria and 
were available in the selected settings at the time of data collection, were taken as case & control 
group samples. 
 
3.7 SAMPLE SIZE 
117 patients with 61 in control group(incident MI) and 56 in case group who fulfilled the 
inclusive criteria. 
  
3.8 CRITERIA FOR SAMPLE SELECTION 
3.8.1 Inclusion Criteria 
Case:  Patient who had 
1. medical history of more than one episodes of MI 
2. recurrent episodes of MI after 28 days of incident MI (first episode) 
Control: Patient who had 
1. medical history of incident MI(only one episode) without recurrence 
2. only incident MI more than one year or more before the period of data collection 
 Both: Patient who  
1. were aged between 30-70 years 
2. were attending Cardiac OPD at FLL Hospital 
3. had their medical records available for review 
4. were willing to participate in the study 
5. could understand Tamil or English 
3.8.2 Exclusion criteria 
Patients who 
1. had severe auditory impairment 
2. had severe cognitive impairment 
3. did not have previous records & reports 
 
3.9 SAMPLING TECHNIQUE 
      Non-probability purposive sampling technique was used to select 117 patients as 
samples from Frontier Life Line Hospital  
 
3.10 DEVELOPMENT & DESCRIPTION OF THE TOOL 
After an extensive review of literature, discussion with the experts and the investigators 
professional experience, the tool was developed to identify the precipitating factors for recurrent 
MI. 
The tool constructed for the study has two sections: 
Part A: Personal data sheet 
Part B: Structured interview schedule 
 
3.10.1 Part A 
Personal data sheet to collect the demographic characteristics consisting of  6 variables 
which included age, gender, education, occupation, family monthly income and marital status  
 
 
3.10.2 Part B 
Structured interview schedule on precipitating factors such as clinical prognostic factors, 
genetic factors, lifestyle factors & dietary factors.The structured questionnaire consists of 63 
questions formulated under separate sub headings to assess the precipitating factors for recurrent 
0, LQ ERWK FRQWURO DQG FDVH JURXS E\ LQWHUYLHZ PHWKRG 7KH FROOHFWHG LQIRUPDWLRQ¶V ZHUH
categorized according to the precipitating factors. 
 
Items No. of questions 
Clinical prognostic Factors 30 
Genetic factor 4 
Life style factor 19 
Dietary factors 10 
Total 63 
 
 Intervention: All the samples in case (recurrent MI) and control group (Incident MI) 
were provided with a pamphlet on prevention of recurrent MI after the data collection. 
 
3.11 CONTENT VALIDITY 
7KHFRQWHQWYDOLGLW\RIWKHGDWDFROOHFWLRQWRROZDVDVFHUWDLQHGZLWKWKHH[SHUW¶VRSLQLRQ
in the following field of expertise 
 Interventional Cardiology ± 2 
 Medical Surgical Nursing ± 4 
 Intensive care unit ± 1 
 3.12 ETHICAL CONSIDERATIONS 
1) Beneficence 
The research study was approved by the  Institutional Ethical Review Board (IERB) of 
International Centre for Collaborative Research (ICCR) of  Omayal  Achi College of Nursing  
(OACN) in the meeting held on December 2014. The study was   beneficial for the 
samples as it enhanced their knowledge through pamphlet about precipitating factors of recurrent 
MI after the results. 
 
a) The right to freedom from harm and discomfort: 
No harm or discomfort was caused to any of the patients during the process of data 
collection. 
 
b) The right to protection from exploitation: 
The investigator explained the procedure and nature of the study to the participants and 
ensured that none of the samples in both control and case group would be exploited or denied 
fair treatment. 
 
2) Respect for human dignity: 
The investigator followed the second ethical principle of respect for human dignity. It 
includes the right to self-determination and the right to self-disclosure 
 
a) The respect to self-determination: 
The investigator provided full freedom to the subjects to decide voluntarily whether to 
participate in the study or to withdraw from the study and the right to ask questions. 
 
b) The right to full disclosure: 
7KH UHVHDUFKHU KDV IXOO\ GHVFULEHG WKH QDWXUH RI WKH VWXG\ WKH SHUVRQ¶V ULJKW WR UHIXVH
SDUWLFLSDWLRQDQGWKHUHVHDUFKHU¶VUHVSRQVLELOLWLHVEDVHGRQZKLFKERWKRUDODQGZULWWHQLQIRUPHG
consent was obtained from the samples. 
 
 3) Justice: 
The researcher adhered to the third ethical principle of justice; it includes samples right to 
fair treatment and right to privacy. 
 
a) Right to fair treatment: 
The researcher selected the study samples based on the research requirements and both 
groups received pamphlet on prevention of recurrent MI. 
b) Right to privacy: 
The researcher maintained the samples  privacy throughout the interview. No photos or 
videos of the patient was taken during data collection procedure. Interview was conducted in the  
consultant waiting room separately for the samples 
 
4) Confidentiality  
The researcher maintained confidentiality of the data disclosed by the study samples. 
Samples were given numbers and their name or other details of the samples was not disclosed in 
any part of the study. Dissemination of study results through conference or journals contain only 
statistical data 
 
3.13 RELIABILITY 
Variables Tool Method Value Inference 
Selected 
factors for 
recurrent MI 
Structured 
Interview 
Schedule 
Inter-rater r = 0.90 Highly reliable 
 
3.14 PILOT STUDY PROCEDURE 
 
                 Pilot study was conducted at Cherian Heart Foundation, Mogappair from 15.05.2015 
to 20.05.2015. A formal written permission was sought from the Principal of Omayal Achi 
College of Nursing, Chairman and Head of the Department of Cardiology of Cherian Heart 
Foundation.A total of 10 samples for control group and case group who fulfilled the inclusive 
criteria for sample selection were selected using non-probability purposive sampling technique. 
The investigator introduced self to the patient and established rapport with the client. A brief 
explanation about the study was given to the patients. After obtaining written consent from 
participants, data collection was commenced.  
               The interview was conducted using structured interview method to assess the 
precipitating factors. With each sample the research investigator spent 20-30 minutes to conduct 
interview. Confidentiality was strictly maintained during the process of data collection 
 
3.14 PROCEDURE FOR DATA COLLECTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Obtained permission from ICCR and Frontier Life Line Hospital authorities 
Patients who were medically diagnosed with incident MI(control) and recurrent MI(case) 
and who fulfilled the inclusion criterias were taken as samples from cardiac OPD of 
Frontier Life Line Hospital. 
Cases and Control 
 Consent obtained, demographic 
details and record reviews done 
initially. Precipitating factors 
assessed by structured interview 
schedule. 
Intervention: Pamphlet on 
³/LIHDIWHUKHDUWDWWDFN´ZDV 
given to both groups after 
data collection 
Study duration: 21st May 
to 20th June2015 
Total no. of samples: 117 
case ± 56 & control ± 61 
Per day: 8-10 samples  
case ± 4 & control -6 
3.16 PLAN FOR DATA ANALYSIS 
 The data was analysed using descriptive & inferential statistics. 
Descriptive Statistics 
1. Frequency and percentage distribution was used  to analyze the demographic variables of 
the samples. 
Inferential statistics 
1. Chi square test to find the association between the precipitating factors and group (case 
and control) 
2. Binary logistic regression analysis odds ratio to measure the association and identify the 
risk. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
CHAPTER 4 
DATA ANALYSIS AND 
INTEPRETATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
DATA ANALYSIS AND INTERPRETATION 
 
This chapter deals with analysis and interpretation of the data collected from 117 samples 
regarding identification of precipitating factors for recurrent MI. The data collected was 
organized, tabulated and analyzed according to the objective. The findings based on the 
descriptive and inferential statistical analysis are presented under the following. 
 
ORGANIZATION OF THE DATA: 
Section 4.1:  Description of selected demographic variables of  both the case and control group. 
 
Section 4.2:  Association of selected clinical prognostic factors, lifestyle, genetic and dietary 
factors between  the case and control group. 
 
Section 4.3:   Identification of precipitating factors for recurrent MI among the group 
 
 
 
 
 
 
 
 
 
 
 
  
SECTION 4.1: DESCRIPTION OF SELECTED DEMOGRAPHIC VARIABLES OF THE 
CASE AND CONTROL GROUP.    
                   
Table 4.1.1: Frequency and percentage distribution of selected demographic variables like 
age, gender, educational status, occupation, marital status and monthly income. 
N = 117 
Sl.No. Demographic variables 
Case (N=56) Control (N=61) 
No. % No. % 
1 Age in years     
 40 ± 50  19 34 17 27.9 
 51 ± 60 26 46.4 32 52.4 
 61 ± 70  11 19.6 12 19.7 
2 Gender     
 Male  31 55.4 31 50.8 
 Female  25 44.6 30 49.2 
3 Education      
 Nonliterate -  -  
 Primary  -  -  
 Higher secondary  30 53.6 33 54 
 Degree  22 39.3 25 41 
 Others  4 7.1 3 5 
4 Occupation      
 Skilled  5 9 9 14.7 
 Technical  19 34 20 32.7 
 Professional  4 7 3 5 
 Homemakers  17 30.4 17 27.9 
 Others  11 19.6 12 19.7 
5 Family monthly income in Rs.     
 <5000 - - - - 
 6000 ± 10,000 12 21.4 11 18 
Sl.No. Demographic variables 
Case (N=56) Control (N=61) 
No. % No. % 
 11, 000 ± 15, 000 18 32.2 22 36 
 >16, 000 26 46.4 28 46 
6 Marital status      
 Single  - - - - 
 Married 54 96.4 60 98.4 
 Widow/ widower  2 3.6 1 1.6 
 Separate  - - - - 
 Divorce  - - - - 
 Others  - - - - 
       
The table 4.1.1 describes that most of the samples in case and control group belongs to 
age group of 51-60yrs who are males with higher secondary education. Most of the samples were 
technical workers, with a family income of >16,000 Rs and were married 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SECTION 4.2: ASSOCIATION OF SELECTED CLINICAL PROGNOSTIC FACTORS, 
GENETIC, LIFESTYLE & BIOPHYSIOLOGICAL FACTORS OF CASE AND 
CONROL GROUP TO IDENTIFY RISK FACTORS FOR RECURRENT 
MYOCARDIAL INFARCTION BETWEEN THE GROUPS. 
Table 4.2.1(a): Association & odds ratio of selected clinical prognostic factors like DM, its 
chronicity and duration of treatment between case and control groups.                                                            
N= 117 
SL. 
No. Clinical Prognostic Factor Cases N= 56 
Control 
N=61 
Chi-
Square 
Value 
Odds 
Ratio 
95% C.I 
(upper limit ± 
lower limit) 
1 History of Diabetes Mellitus  2=0.822 
d.f = 1 
p = 0.364 
N.S 
  
 Yes 38 46 0.688 0.30-1.54 
 No(reference) 18 15 - - 
2 If yes chronicity of DM  
2=9.409 
d.f = 3 
p = 0.024 
S* 
- - 
 <12 months - - - - 
 1-5 yrs(reference) 5 0 - - 
 6-10 yrs 13 26 1.25* 0.27-5.6 
 >10yrs 20 20 0.93 0.22- 3.8 
 NA 18 15 - - 
3 Treatment  for DM  
2=9.4096 
d.f = 3 
p = 0.024 
S* 
- - 
 <12 months - - - - 
 1-5 yrs(reference) 5 0 - - 
 6-10 yrs 13 26 1.25* 0.27-5.6 
 >10yrs 20 20 0.93 0.22- 3.8 
 NA 18 15 - - 
S* - Significant S* - Highly Significant S*** - Very high significant * - Precipitating factor 
 
The analysis in the table no. 4.2.1(a) shows no significant association for DM but shows a 
significant association  between the chronicity and treatment  duration of diabetes mellitus and 
recurrent MI at p<0.05.  
The corresponding odds ratio for both these variables is 1.25,which indicates that samples 
with 6-10yrs of chronicity and treatment duration of  DM are  at risk of developing recurrent MI 
when compared to samples with lesser chronicity and treatment duration. 
Table 4.2.1(b):   Association & odds ratio of selected  clinical prognostic factors like HT, its 
chronicity and duration of treatment between case and control groups.   
N= 117 
Sl 
No. Clinical Prognostic Factor 
Cases 
N= 56 
Control 
N=61 
Chi-
Square 
Value 
Odds 
Ratio 
95% C.I 
(upper limit 
± lower 
limit) 
1 Hypertension   2=0.343 
d.f = 1 
p = 0.558 
N.S 
- - 
 Yes 36 36 1.25* 0.59- 2.65 
 No(reference) 20 25 - - 
2 If yes chronicity of HT   
 
 
2=8 
d.f = 2 
p = 0.046 
S* 
- - 
 <12 months - - - - 
 1-5 yrs - - - - 
 6-10 yrs(reference) 12 24 - - 
 >10yrs 24 12 1.57
* 0.62- 4 
 NA 20 25 - - 
3 Treatment for HT    
2=7.3076 
d.f = 3 
p = 0.062 
N.S 
- - 
 <12 months - - - - 
 1-5 yrs(reference) 5 2 - - 
 6-10 yrs 11 22 1.08
* 0.25 ± 4.6 
 >10yrs 20 12 2.37* 0.55-10.19 
 NA 20 25 - - 
S* - Significant S* - Highly Significant S*** - Very high significant   *-Precipitating factor 
 
The analysis in the table 4.2.1 (b) shows no significant association between hypertension 
and recurrent MI at p<0.05. The corresponding odds ratio of 1.250 which implies hypertension is 
a precipitating factor  for recurrent MI.With regard to chronicity of HT, there is a significant 
association  between the groups and  the odds ratio.1.57 indicates that  samples with longer 
duration of HT are at risk of developing recurrent MI in comparison to samples with shorter 
duration. 
With regard to treatment duration, there is no significant association between the groups, 
2.37 odds ratio states that longer treatment duration for HT increases the risk two times for 
developing recurrent MI.  
 
Table 4.2.1(c): Association & odds ratio of selected clinical prognostic factors like episodes 
of anginal pain during hospitalization after thrombolysis and drug compliance between 
case and control groups             N = 117 
Sl 
No. Clinical Prognostic Factor 
Cases 
N=56 
Control 
N=61 
Chi-
Square 
Value 
Odds 
Ratio 
95% C.I 
(upper 
limit ± 
lower limit) 
1 Episodes of angina pain after 
thrombolysis 
  
2=14.28 
d.f = 3 
p = .062 
N.S 
  
 No(reference) 15 32 - - 
 1 17 13 2.79* 1.08 ± 7.19 
 2 12 3 3.85* 2.09 ± 34.81 
 3 2 0 - - 
 NA 10 13 -  
2 Adherence to drug therapy   
 - - 
 Regular 56 61 
 Irregular - - 
 discontinued - - 
3 If irregular or discontinued   
 - - 
 Reason - - 
 Expensive - - 
 Alternative treatment - - 
 Side effect - - 
 Others - - 
 NA 56 61 
S* -Significant  S*- Highly Significant   S***- Very high significant *- Precipitating factor 
 With regard to episodes of anginal pain, table 4.2.1(c) shows a significant association 
between number of episodes and recurrent MI at the level of p<0.05, and the odds ratio for a 
single episode is 2.790 and for two episode is 3.853. This implies that risk for developing 
recurrent MI increases two fold in sample with one episode and  three fold  in samples with two 
episodes of anginal pain  in comparison to samples with no episode. 
Table 4.2.1(d):  Association & odds ratio of selected clinical  prognostic factors like    
rehabilitation programme, health checkups and its duration between case and control 
groups.                                                                                                               
                                                           N=117 
Sl 
No. Clinical Prognostic Factor 
Cases 
N=56 
Control 
N=61 
Chi-
Square 
Value 
Odds 
Ratio 
95% C.I 
(upper 
limit ± 
lower limit) 
1 Rehabilitation programme   2=4.4389 
d.f = 1 
p = 0.035 
S* 
- - 
 Yes 16 29 - - 
 No(reference) 40 32 2.26
* 1.05 -4.9 
2 Health check ups   
2=1.099 
d.f = 1 
p = 0.295 
N.S 
- - 
 Regular 55 61 
 Irregular 1 0 
 Others - - 
3 Duration of health check 
ups  
  
2=31.763 
d.f = 3 
p = 0.000 
S*** 
- - 
 Monthly once(reference) 36 15 - - 
 Every 3 months 15 11 0.56 0.21-1.5 
 Every 6 months 3 16 0.78 0.20 ± 0.30 
 Yearly once 2 19 0.04 0.01-0.21 
S* - Significant S* - Highly Significant S*** - Very high significant * - Precipitating factor 
      The analysis in the table 4.2.1 (d) shows a significant association between participation in 
UHKDELOLWDWLRQSURJUDPPHDQGUHFXUUHQW0,DWSZLWKFRUUHVSRQGLQJRGG¶VUDWLR7KH
result implies samples who have not participated in  rehabilitation programme  is twice  at risk of 
developing recurrent MI in comparison to samples who have attended rehabilitation programme. 
      The analysis in the table 4.2.1 (d) shows a significant association between duration of 
health checkups and recurrent MI at p<0.05. The odds ratio indicates that frequent reviews for 
MI is a protective factor against recurrent MI. 
Table 4.2.1 (e): Association & odds ratio of selected Clinical prognostic factor (bio-
physiological measures) like BMI, central obesity and blood pressure between case and 
control group. 
                                                                                                                                   N =117 
Sl 
No. Bio ±physiological factors 
Case 
N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(Upper limit-
lower limit) 
1 BMI  
2=0.965 
d.f = 2 
p = 0.617 
N.S 
  
  - - - - 
 18.5-24.9(reference) 26 31 - - 
 25-29.9 20 23 1.03
* 0.46 ± 2.29 
  10 7 1.70* 0.56 ± 5.10 
2 Central Obesity     
 Male  
2= .2605 
P=O.6097 
NS 
- - 
 .95 or below -- -- - - 
 .96 to 1(reference) 15 13 - - 
 1+ 16 18 1.29* 0.89 ± 4.23 
 Female  
2= 2.055 
P=0.1516 
NS 
- - 
 .80 or below -- -- - - 
 .81 to .85(reference) 11 19 - - 
 .85+ 14 11 1.45* 0.23 ± 3.45 
3 Blood pressure  
2=8.126 
d.f = 2 
p = 0.017 
S** 
- - 
 SBP 100-140 DBP 60-
90(ref) 
12 28 - 
- 
 SBP 140-159 DBP 90-99 27 18 3.50
* 1.42 ± 8.62 
 6%3PPKJ'%3 17 15 2.64* 1 ± 6.97 
S*- Significant  S*- Highly Significant S*** - Very high significant * - Precipitating factor 
 
      The table shows no significant association  between BMI and recurrent MI among the 
groups. The corresponding odds ratio indicates that samples with BMI 25-29.9 are 1.037 times 
ULVNRIGHYHORSLQJUHFXUUHQW0,DQGZLWK%0,DUHWLPHVULVN of developing recurrent 
MI. 
 
      With regard to central obesity there is no significant association between the groups. The 
odds ratio for males, 1.298 implies that samples with >1 index for central obesity is at risk of 
developing recurrent MI in comparison to samples with <1 and it is a precipitating factor.The 
same table shows no significant association between case and control group with regard to 
central obesity for females, the odds ratio 1.454 indicates that samples with index > 0.85 are at 
risk of developing recurrent MI. 
 
The analysis table shows a significant association between case and control group with 
regard to blood pressure. The corresponding odds ratio 3.50 indicates samples with BP140-
159/90-99 is three times at risk of developing recurrent MI when compared to normotensive 
individuals. The corresponding odds ratio 2.64 LQGLFDWHVVDPSOHVZLWK%3LVWwo times 
greater risk of developing recurrent MI when compared to normotensive individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2.1(f):   Association & odds ratio of selected Clinical prognostic factors (record 
reviews) like revascularization procedure, type and location of infarction between case and 
control groups.                                                                                                               
N = 117 
Sl 
No. Record reviews Case N=56 
Control 
N=61 
Chi 
square 
Odds 
ratio 
95% C.I 
(lower limit ±
upper limit) 
1 Revascularization procedure  2=4.472 
d.f = 1 
p = 0.034 
S** 
- - 
 Yes 45 57 3.91* 1.62 ± 9.44 
 No(reference) 11 4 - - 
2 If yes, type of 
revascularization procedure 
 
2=15.080 
d.f = 3 
p = 0.001 
S*** 
- - 
 CABG 23 23 1 0.43 ± 2.28 
 PTCA(reference) 22 22 - - 
 Both 0 12 - - 
 NA 11 4 - - 
3 Type of infarction  2=6.583 
d.f = 1 
p = 0.010 
S** 
- - 
NSTEMI 38 27 2.658
* 1.25 ± 5.65 
 STEMI(reference) 18 34 - - 
4 Location of infarction  2=5.7237 
d.f = 1 
p = 0.016 
S** 
- - 
 Non-transmural 18 33 2.488* 0.90 ± 4.06 
 Transmural(reference) 38 28 - - 
S*-Significant  S*-Highly Significant  S*** -Very high significant * - Precipitating factor 
 
The table shows a significant association with regard to revascularization procedure 
between the groups and the odds ratio 0.287 shows that samples who had underwent 
revascularization procedure are less likely to develop recurrent MI. The table also shows a 
significant association for type of revascularization procedure between case and control group.  
With regard to type of infarction, table shows a significant association between case and 
control group. The corresponding odds ratio for both the variables are 2.658 and 2.488  
respectively, which indicates samples with NSTEMI and non-transmural type of infarction are 
twice the risk of developing recurrent MI in comparison to STEMI and transmural type of 
infarction. 
Table 4.2.1(g): Association & odds ratio of selected clinical prognostic factors (record 
reviews) like management of DM, HT and MI between case and control group.                        
N=117 
Sl 
No. Record reviews Case N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95 % C.I 
(lower limit ± 
upper limit) 
1 Management of DM   
2=5.27 
d.f = 2 
p = 0.260 
N.S 
- - 
 OHA(reference) 19 19 - - 
 Insulin 11 12 0.91 0.9 ± 0.325 
 Both  8 17 0.47 0.47 ± 0.16 
 Alternative medicine 0 1 - - 
 NA 18 12 - - 
2 Management of MI   
2=19.35
3 
d.f = 2 
p = 0.000 
S*** 
- - 
 Ca Channel 
blockers/antiplatelets 
13 18 1.44 0.12- 17.6 
 B blockers/antiplatelets 19 21 1.81 0.15 ± 21.5 
 All three 23 20 2.30* 0.19 ± 27.3 
 Others  1 2 - - 
3 Management of HT   
2=1.631 
d.f =5 
p = 0.803 
N.S 
- - 
 Ca channel blockers  7 8 0.61 0.15 ± 2.48 
 Angiotensin II receptor 
blockers  
3 4 0.52 0.08 ± 3.5 
 ACE inhibitors  5 8 0.43 0.1 ± 1.2 
 B blockers  11 9 0.85 0.23 ± 3.1 
 More than one 
(reference)  
10 7 - - 
 NA  20 25 - - 
S*- Significant S*- Highly Significant  S*** - Very high significant *- Precipitating factor 
 
      The analysis table shows no significant association between case and control group. 
Samples taking both oral hypoglycemic agent and insulin are reduced risk of developing 
recurrent MI in comparison to samples taking only insulin as indicated by  the odds ratio  0.471.   
With regard to management of HT, there is no significant association between case and 
control group. Among the drugs, odds ratio for ACE inhibitors is less (ie) 0.43 which indicates 
that samples taking ACE inhibitors for HT are at lesser risk for developing recurrent MI.  
 
With regard to management of MI, there is no significant association between case and 
control group. The odds ratio was high for samples who are taking all three classes of drugs(Ca- 
Channel blockers, B-blockers and antiplatelets) of  2.30 when comparing to samples who are 
taking calcium channel blockers & antiplatelets(1.44) and for B-blockers & antiplatelets(1.81). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2.1(h) : Association & odds ratio of selected clinical prognostic factors (record 
reviews) like past history of  cerebrovascular accident, heart disease and autoimmune 
disorders  between case and control group.             
N=117                        
Sl 
No. Record reviews Case N=56 
Control 
N=61 
Chi 
square 
Odds 
ratio 
95% C.I 
( lower limit ± 
upper limit) 
1 Past history of   
2=4.610 
d.f = 3 
p = 0.203 
N.S 
- - 
 Nil  48 56 - - 
 CVA 2 2 1.167
* 0.15 ± 8.5 
 Autoimmune 4 0 - - 
 heart disease 2 3 0.78 0.12 ± 4.8 
2 Autoimmune 
disorders 
  
2=4.511 
d.f = 2 
p = 0.104
N.S 
- 
 
 RA  3 0  
 SLE  1 0 - 
 SS - -  
NA 52 61
3 Heart disease   
2=2.216 
d.f = 1 
p = 0.330 
N.S 
- 
 
 Nil  54 61 
- 
 RHD 1 0
 Valvular disorders 1  
 Others - - 
S* - Significant S*- Highly Significant S***- Very high significant * - Precipitating factor 
 
      The table shows no significant association between case and control group. Samples with 
previous history of CVA are 1.167 times greater risk of developing recurrent MI in comparison 
to autoimmune disorders and heart disease. 
 
 
 
 
Table 4.2.1(i): Association & odds ratio of selected clinical prognostic factors (record 
reviews) co-morbid illness between case and control group.                                                                                
                           N= 117 
Sl 
No. Record reviews Case N=56 
Control 
N=61 
Chi 
square 
Odds 
ratio 
95% C.I 
(lower limit ± 
upper limit) 
1 Co-morbidity   
2=1.020 
d.f = 3 
p = 0.796 
N.S 
  
 Nil 31 36   
 Resp. disease 12 10 1.39* 0.53 ± 3.66 
 Renal prob 7 6 1.35* 0.41 ± 4.46 
 Vascular disorders 6 9 0.77 0.24 ± 2.41 
2 Resp. disease   
2=5.204 
d.f = 3 
p = 0.157 
N.S 
- - 
 NA 44 51 
 Asthma 5 8
 COPD 3 2
 Sleep apnea - - 
 Others 4 0
3 Renal problems   
2=4.092 
d.f = 2 
p = 0.129 
N.S 
- - 
 Nil  49 55 
 Calculi 2 5
 Infections 5 1
 Others - - 
4 Vascular disease   
2=0.426 
d.f = 1 
p = 0.514 
N.S 
- 
- 
 Nil  50 52 
 DVT - - 
 Varicose veins 6 9
 Bleeding disorders - - 
 Others     
S* - Significant S*- Highly Significant S*** - Very high significant * - Precipitating factor 
 
      The table shows no significant association between case and control group with regard to 
co-morbid illness. Samples with co-morbid illness like respiratory (1.394) and renal 
disease(1.355) are at risk of developing recurrent MI when compared to vascular disorders. 
4.2.2: Association & odds ratio of selected  genetic factors like family history of  heart 
disease and hypertension between case and control groups. 
               N=117 
Sl 
No. Genetic factors Case N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit ± 
lower limit) 
1 Family history of heart disease     - - 
 Paternal  10 8 
2= 2.346 
d.f = 3 
p=.504 
N.S 
1.250 0.44 ± 3.5 
 Maternal 3 6 0.78 0.11 ± 2.14 
 Both - - - - 
 Sibling 4 8 0.500 0.13 ± 0.17 
 More than one - - - - 
 Nil(reference) 39 39 - - 
2 Family history of Hypertension  
2=9.717 
d.f = 5 
p = 0.084 
N.S 
- - 
 Paternal  13 24 0.42 0.16-1.11 
 Maternal 8 14 0.45 0.15 ± 1.35 
 Both 11 5 1.73* 0.49 ± 6.09 
 Sibling 5 2 1.97* 0.33 ± 1.63 
 More than one 0 1 - - 
 Nil(Reference) 19 15 - - 
3 Family history of Diabetes 
Mellitus 
 
2=8.518 
d.f = 5 
p = 0.130 
N.S 
- 
- 
 -Paternal  21 19 0.71 0.26 ± 1.90 
 Maternal 6 14 0.27 0.08 ± 0.94 
 Both 8 15 0.34 0.11 ± 1.08 
 Sibling 2 0 - - 
 More than one 2 2 0.64 0.07 ± 5.29 
 Nil(reference) 17 11 - - 
4 Family history of Dyslipidemia    
2=11.304 
d.f = 5 
p = 0.010 
S** 
- - 
 Paternal  7 2 4.95* 0.97 ± 25 
 Maternal 4 1 5.65* 0.61 ± 52.4 
 Both - - - - 
 Sibling 4 0 - - 
 More than one - - - - 
 Nil 41 58 - - 
S* - Significant S* - Highly Significant S*** -Very high significant * - Precipitating factor 
 
The analysis in the table 4.2.2 shows no significant association between the groups with 
regard to family history of heart disease and recurrent MI. The odds ratio of 1.250 for paternal 
history of heart disease, maternal history is 0.78 and sibling history is 0.500, indicating sample 
with history of paternal heart disease carries highest risk in comparison to sample with other 
familial history of heart disease. 
 
The analysis in the table 4.2.2(a) shows no significant association between family history 
of hypertension and recurrent MI among the groups. The odds ratio for sample with both paternal 
and maternal history of hypertension is 1.737 and for sibling history is 1.974 which indicates 
sample with both paternal and maternal history and sibling history  of hypertension are at risk of 
developing recurrent MI in comparison to sample with other familial history of hypertension. 
 
The analysis in the table 4.2.2(a) shows no significant association between family history 
of DM and recurrent MI  among the groups. The odds ratio, 0.277  for maternal history of DM 
indicates samples with maternal history of DM are less likely to develop recurrent MI when 
compared to samples with paternal, both(paternal and maternal) or multiple family history of 
DM. 
 
With regard to family history of dyslipidemia, the table 4.2.2(a) shows a significant 
association between the groups at p<0.05. Both paternal and maternal family history of 
dyslipidemia were identified as precipitating factors with maternal history showing greater risk 
for recurrent MI than the former. 
 
 
 
 
 
4.2.3(a): Association & odds ratio of selected life style factors like working hours, night 
shift and its duration per week between case and control groups.                                                                       
               N= 117 
Sl 
No. Life style factors Case N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit ± 
lower limit) 
1 Working hours/day   
2=6.965 
d.f = 3 
p = 0.073 
N.S 
- - 
 KUV - - - - 
 5-10 hrs(reference) 27 33 - - 
 10-15hrs 17 8 2.59
* 0.97 ± 6.93 
 KUV 4 11 0.44 0.12  - 1.55 
 NA 8 9 - - 
2 Night shift   2=0.039 
d.f = 1 
p = 0.844 
N.S 
- - 
 Yes  9 9 1.10* 0.40 ± 3.02 
 No(reference) 47 52 - - 
3 Weeks/month    
2=0.039 
d.f = 1 
p = 0.844 
N.S 
- - 
 <2wk 9 9 
 >2wk - - 
 NA 47 52 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
      The table 4.2.3(a) shows no significant association between working hours per day and 
recurrent MI. The odds ratio 2.59 indicates that samples who  work for about 10-15 hrs are at 
twice the  risk of developing recurrent MI with reference to sample working for less than 10 
hours and hence it is a precipitating factor. 
 
 The table 4.2.3(a) shows no significant association between night shift and recurrent MI 
among the groups. The odds ratio of 1.106 shows that samples working at night are at risk of 
developing recurrent MI when compared to samples those who work only during the day. Hence 
night shift is a precipitating factor. 
Table 4.2.3 (b): Association & odds ratio of selected life style factors like leisure time, sleep 
pattern and its duration between case and control groups.   
                             N = 117 
Sl 
No. Life style factors 
Case 
N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit 
± lower limit) 
1 Leisure time   
2=30.689 
d.f = 2 
p = 0.000 
S*** 
 
 
- 
 
- 
 Nil 0 19 
 <5hrs 56 35 
 <10hrs 0 7
 <15hrs - - 
 >15hrs - - 
2 Sleep pattern   
2=7.000 
d.f = 1 
p = 0.008 
S** 
- - 
 Uninterrupted 
sleep(reference) 
27 44 - 
- 
 Interrupted sleep 29 17 2.78* 1.29 ± 5.98 
3 Duration of sleep  
2=20.721 
d.f = 2 
p = 0.000 
S*** 
  
 KUV 18 4 4.20* 1.3 ± 13.9 
 6-10hrs(reference) 30 28 - - 
 >10hrs 8 29 0.65 0.26 ± 0.10 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
                 
      With regard to sleep pattern and duration, the table 4.2.3(b) shows significant association 
between groups against recurrent MI.  The odds ratio of 2.780 for interrupted sleep pattern and 
IRU GXUDWLRQ RI VOHHS LV  KUV7KHVH YDOXHV LQGLFDWHV WKDW VDPSOHVZLWK GLVWXUEHG VOHHS
SDWWHUQKDYHWZLFHWKHULVNRIGHYHORSLQJUHFXUUHQW0,DQGWKRVHZLWKKUVduration of sleep 
are 4 times greater risk of recurrent MI. 
 
 
 
 
 
Table 4.2.3(c):   Association & odds ratio of selected life style factors like smoking and  
current status of smoking between case and control groups.  
                                                                                                                                  N = 117 
Sl 
No. Life style factors Case N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit ± 
lower limit) 
1 Smoker   2=0.343 
d.f = 1 
p = 0.558 
N.S 
- - 
 Yes 36 36 1.250* 0.59 ± 2.64 
 No(reference) 20 25 - - 
2 Current status of smoking   
2=1.075 
d.f = 3 
p = 0.783 
N.S 
- - 
 Active 2 2 3.93* 0.12 ± 7.08 
 Former 2 4 0.46 0.80 ± 2.74 
 Quitter(Reference) 32 30 - - 
 NA 20 25 - - 
3 Cigarettes/day   
2=4.015 
d.f = 2 
p = 0.134
N.S 
- - 
 <2 0 2 
 3 to 5 2 0 
 >6 - - 
 NA 54 59 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
       The table 4.2.3(c) shows no significant association between smoking and recurrent MI 
between the groups. The odds ratio  which shows that smokers are at 1.250 time greater risk of 
developing recurrent MI when compared to non-smokers and hence it is a precipitating factor. 
 
      The tables also shows no significant association between smoking status and recurrent MI 
among the groups. The odds ratio for active smokers is 3.938 which indicates samples who are 
active smokers are three times greater risk for developing recurrent MI in comparison to former 
smokers and quitters. 
 
 
Table 4.2.3(d):  Association & odds ratio of selected life style factors like duration of 
smoking  and cessation between case and control groups.    
N = 117 
Sl 
No. Life style factors Case N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit ± 
lower limit) 
1 Duration of smoking   
2=14.119 
d.f = 3 
p = 0.003 
S*** 
- - 
 <3 yrs - - - - 
 4-6 yrs(reference) 10 21 - - 
 7-9 yrs 14 15 - - 
 >10 yrs 12 0 1.633* 0.59 ± 4.51 
 NA 20 25 - - 
2 Duration of cessation   
2=10.262 
d.f = 4 
p = 0.036 
S* 
  
 0 to <6 months - - - - 
 6 to <18 months 9 7 - - 
 18 to <36 months 14 7 5.8* 6.84 ± 446.1 
 36 to <48 months 10 10 5.6
* 1.067 ± 30.08 
 48 to 60 months 
(reference) 
1 10 - 
- 
 NA 22 27 - - 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
      The table 4.2.3(d) shows a significant association between duration of smoking and 
recurrent MI at 0.01. The odds ratio, 1.633 implies that samples who  are smoking for more than 
ten years are at risk of developing recurrent MI in comparison to samples who are smokers for 
<10 years and it is a precipitating factor. 
 
      The table shows that there is no significant association between duration of cessation of 
VPRNLQJDQGUHFXUUHQW0,7KHRGG¶VUDWLRLQGLFDWHVWKDWWKHULVNRIUHFXUUHQW0,LQFUHDVHVWR
times in samples with duration of cessation  for <36 months and for samples with duration of 
cessation between 36 to 48 months risk is 5.6 times. 
Table 4.2.3(e):  Association & odds ratio of selected life style factors like alcohol, types and 
amount of consumption between case and control groups. 
N = 117 
Sl 
No. Life style factors 
Case 
N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit 
± lower limit) 
1 Are u a Alcoholic?   2=0.046 
d.f = 1 
p = 0.831 
N.S 
  
 Yes 4 5 1.09* 0.30 ± 4.01 
 
No(reference) 52 56  
 
2 Type of drinker   2=0.046 
d.f = 1 
p = 0.831 
N.S 
- - 
 Regular - - 
 Weekly - - 
 Social  occasions 4 5 
 NA 52 56 
3 Type of alcohol   
2=5.745 
d.f = 2 
p = 0.057 
N.S 
- - 
 Wine - - 
 Liquor 4 1 
 Beer 0 4 
Others - -
 NA 52 56 
4 Alcohol/day   2=3.226 
d.f = 2 
p = 0.199 
N.S 
- 
 
 1 2 5 
- 
 2 2 0 
  - - 
 NA 52 56 
5 Amount of alcohol    2=0.046 
d.f = 1 
p = 0.831 
N.S 
- - 
 NA 52 56 
 PO - - 
 180-260 ml 4 5 
 PO - - 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
The table 4.2.3(e) with regard to consumption of alcohol shows no significant association 
between case and control group. The corresponding odds ratio indicates that alcoholics are 1.098 
time greater risk of developing recurrent MI. 
Table 4.2.3(f): Association & odds ratio of selected life style factors like exercise, duration 
and types between case and control groups. 
                          N=117 
Sl 
No. Life style factors 
Case 
N=56 
Control 
N=61 
Chi 
square 
value 
Odds 
ratio 
95% C.I 
(upper limit 
± lower limit) 
1 Exercise habit   2=1.937 
d.f = 1 
p = 0.163 
NS 
- - 
 Yes 24 34 0.59 0.26 ± 1.62 
 No(reference) 32 27 - - 
2 If yes, duration/wk   
2=11.621 
d.f = 2 
p = 0.002 
S** 
- - 
 <7hrs - - - - 
 8-14hrs(reference) 3 18 - - 
 >15hrs 21 16 0.160 0.94 ± 2.71 
 NA   32 27 - - 
3 Type of exercise   
2=8.53 
d.f = 3 
p = 0.014 
S* 
-- 
 
 Walking 24 24  
 Jogging - -  
 Aerobics 0 5 - 
 Yoga 0 5  
 NA 32 27  
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
      The table 4.2.3(f) shows no significant association between habit of doing exercise and 
recurrent MI. The corresponding odds ratio,0.595 shows it as a protective factor against recurrent 
MI. 
 
      There is a significant association between case and control group with regard to duration 
of exercise, The odds ratio, 0.160 indicates that exercise duration for more than 15 hrs per week 
is a protective factor against recurrent MI. 
 
 
 
Table 4.2.4(a):  Association & odds ratio of selected dietary factors like type of diet, 
frequency of non-veg foods and type between case and control groups 
N=117 
Sl 
No. Dietary factors 
Case 
N=56 
Control 
N=61 
Chi 
Square 
value 
2GG¶V
ratio 
95% C.I 
(upper limit 
± lower limit) 
1 Dietary pattern  2=1.976 
d.f = 1 
p = 0.160 
N.S 
- - 
 Vegetarian(reference) 16 25 1.73* 0.80 ± 3.75 
 Non-vegetarian 42 36 - - 
 Ova vegetarian - - - - 
2 Freq of non vegetarian foods  
2=3.640 
d.f = 2 
p = 0.160 
N.S 
- - 
 Once/wk(reference) 27 29 - - 
 Twice/wk 13 7 0.50 0.69 ± 5.47 
 Thrice/wk - - - - 
 >4times - - - - 
 NA 16 25 - - 
3 Type of non-veg foods  
2=26.00
3 
d.f = 4 
p = 0.000 
S*** 
- - 
 Chicken 12 10 1.87* 0.65 ± 5.34 
 Mutton 7 7 1.56* 0.46 ± 5.29 
 Fish  13 15 1.35* 0.51 ± 3.58 
 Pork - -- - - 
 Beef - - - - 
 More than one    
 NA(reference) 16 25 - - 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
The table 4.2.4(a) shows no significant association with regard to type of diet between 
case and control group. The odds ratio is 1.736 which implies that non-vegetarian diets increase 
the risk of developing recurrent MI and it is a precipitating factor. 
The table 4.2.4(a) does not show any significant association between frequency of non-
vegetarian food as and recurrent MI. The corresponding odds ratio 0.501 indicates samples 
consuming non-vegetarian diet once a week are less likely to develop recurrent MI in 
comparison to other  frequency of consumption.
With regard to type of non vegetarian diets, there is significant association between the 
groups. The corresponding odds ratio for chicken is 1.8, mutton is 1.56 and for fish is 1.35. out 
of which intake of chicken carries the highest risk for developing recurrent MI. 
Table 4.2.4(b):   Association & odds ratio  of selected dietary factors like intake of green     
leafy vegetables and fruits between case and control groups     
.                                                                                                               N = 117 
Sl 
No. Dietary factors 
Case 
N=56 
Control 
N=61 
Chi 
Square 
value 
2GG¶V
ratio 
95% C.I 
(upper limit 
± lower limit) 
1 Green leafy vegetables   2=16.32
2 
d.f = 1 
p = 0.000 
S*** 
  
 Daily(reference) 54 41 - - 
 More than three times/wk 2 20 0.075 0.01 ± 0.34 
 Thrice/wk - - - - 
 Twice/wk - - - - 
 Once/wk - - - - 
2 Fruits   
2=2.877 
d.f = 1 
p = 0.090 
N.S 
- - 
 Daily(reference) 31 43 - - 
 More than three times/wk 25 18 1.926* 0.89 ± 4.12 
 Thrice/wk - - - - 
 Twice/wk - - - - 
 Once/wk - - - - 
3 Cooking style   2=5.690 
d.f = 1 
p = 0.017 
S* 
- 
 
 Boiling  51 61 - 
 
Frying 5 0 
 
4 Fried foods   2=4.511 
d.f = 2 
p = 0.105 
N.S 
- 
 
 More than three times/wk 52 61  
 Thrice/wk 3 0 - 
 Twice a wk 1 0  
 Once a wk - -  
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
      The table 4.2.4(b) shows a significant association between case and control group with 
regard to intake of green leafy vegetables. The odds ratio 0.075 indicates samples consuming 
green leafy vegetables daily are less likely to develop recurrent MI when compared to samples 
taking greens for more than three times a week and it is a protective factor.  
 
The table 4.2.4(b) does not show significant association between case and control group 
with regard to intake of fruits. The odds ratio indicates samples who are not consuming fruits on 
a daily basis are 1.926 times risk of developing  recurrent MI. 
 
Table 4.2.4(c):  Association & odds ratio of selected dietary factors like intake of salt, sugar 
and preserved foods between case and control groups.       
                                                                                                                                 N = 117                                      
Sl 
No. Dietary factors Case N=56 
Control 
N=61 
Chi 
Square 
value 
2GG¶V
ratio 
95%C.I 
(upper limit 
± lower 
limit) 
1 Salt/day   
2=11.91 
d.f = 2 
p = 0.003 
S** 
- - 
 <1 46 61 
 2 7 0
 3 3 0
 >4 - - 
2 Sugar/day   
2=13.226 
d.f = 2 
p = 0.000 
S*** 
- - 
 <1 45 61 
 2 11 0
 3 - - 
 >4 - - 
3 Preserved food 
intake 
  
2=1.972 
d.f = 2 
p = 0.373 
N.S 
- - 
 Daily - - - - 
 >Thrice a week - - - - 
 Twice a wk 1 0 - - 
 Once a wk 5 9 0.57 0.18 ± 1.84 
 Rare(reference) 50 52 - - 
S*-Significant  S*- Highly Significant S*** -Very high significant * - Precipitating factor 
 
With regard to preserved foods, the table 4.2.4(c) shows no significant association  
between case and control group. The odds ratio is 0.578 which implies samples consuming 
preserved foods at rare occasions are less likely to develop recurrent MI I comparison to 
consuming preserved foods twice a week. 
 
  
SECTION 4.3: IDENTIFICATION OF PRECIPITATING FACTORS FOR 
RECURRENT MI AMONG THE GROUP. 
 
  Table 4.3.1: Odds ratio of clinical prognostic factors for recurrent MI 
 
S.No Clinical Prognostic Factors Odds ratio 
1 2 Episodes of anginal pain after thrombolysis  3.85  
2 Blood Pressure 140-159/90-99  3.50  
3 1 episode of anginal pain  2.79  
4 NSTEMI  2.65  
5 %ORRGSUHVVXUHPP+JPP+J 2.64  
6 Non-Transmural infarction  2.48  
7 Treatment duration for HT>10years  2.37  
8 %0, 1.70  
9 Chronicity of HT  1.571  
10 Central obesity >85+ females  1.454  
11 Co-morbidity ± respiratory disease  1.394  
12 Co-morbidity ± renal disease  1.355  
13 Central obesity>1+ index(males)  1.298  
14 Chronicity of DM 6-10years  1.250  
15 Treatment duration for DM 6-10 yrs  1.250  
16 Hypertension  1.250  
 
 
The above table indicates the precipitating factors for recurrent MI with regard to 
clinical prognostic factors in a descending pattern of odds ratio.
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CHAPTER 5 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The study was conducted to identify the precipitating factors for recurrent MI. The 
discussion is based on the objectives, literature review and hypothesis specified in the study. 
5.1  The findings of the demographic variables of the case and control group 
                 The samples in case and contol group were males between age group of 51-60 yrs and have 
undergone higher secondary education. Most of the samples were technical workers, with a 
family income of >16,000 Rs and were married 
5.2: The objective of the study was to find the association of selected clinical prognostic 
factor, genetic factors, life style factors and  dietary factors  
 
The chi square result of the above mentioned objectives are as follows, 
 
5.2.1 Clinical prognostic factors: 
It includes factors like Diabetes mellitus Hypertension, episodes of angina pain during 
hospitalization, participation in rehabilitation programme, body mass index, central obesity, , 
non-adherence to drug therapy, type of infarction, location of infarction, history of  co-morbid 
illness. 
 
5.2.1 (a) Diabetes Mellitus 
The analysis in the table no. 4.2.1(a) shows significant association between duration of 
diabetes mellitus and recurrent MI at p<0.05. 
 
The pathogenesis behind this factor is diabetic patients have impaired fibrinolytic 
potential, higher platelet aggregability, and higher fibrinogen levels. These hematologic factors 
exposure for a longer duration contributes to recurrent infarction, a common complication among 
diabetic individuals. 
 
This findings was supported by Kenneth.J.Mukamal .et al ., conducted a prospective 
cohort study  to  assess the impact of diabetes on recurrent myocardial infarction and its 
comparability of risk with prior myocardial infarction. A total of 399 patients records were 
reviewed by trained officers and face to face interviews with patients. The results implies the 
effect of diabetes was not significantly modified by age, smoking, household income, use of 
thrombolytic therapy, type of hypoglycemic treatment, but the risk associated with diabetes was 
its duration. 
 
5.2.1 (b) Hypertension 
The analysis in the table 4.2.1 (b) shows a significant association between duration of 
hypertension and recurrent MI at p<0.05. 
 
The analysis in the table 4.2.5 (a) shows a significant association between blood pressure 
DQGUHFXUUHQW0,DWSZLWKDFRUUHVSRQGLQJRGG¶VUDWLRZKLFKLQGLFDWHGQRUPRWHQVLYH
is a protecting factor against recurrent MI 
 
The mechanism was explained by Claudio Picariello et al., in a study to assess  the 
impact of hypertension on patients with acute coronary syndromes, being chronic hypertensive 
state causes cardiac hypertrophy which is an independent risk factor for myocardial infarction. 
Left ventricular hypertrophy is associated with increased oxygen demand leading to the 
development of collateral circulation to supply the myocardium. This collateral circulation, 
driven by pressure gradient  results in more exposure to ischemia and infarction which 
subsequently leads to recurrent events. 
 
5.2.1 (c). Episodes of angina pain during hospitalization 
The analysis in the table 4.2.1 (c) shows association of case and control group with their 
episodes of angina pain. 
 
With regard to episodes of angina pain, there is a significant association between number 
of episodes and recurrent MI at the level of p<0.05, and the corresponding odds ratio is 0.644. 
This implies that patient with less than 3 episodes of anginal pain after incident MI are a 
protective factor for recurrent MI. 
 
The mechanism which relates episodes of angina pain with recurrent MI is that  the 
infracted artery reocculdes following a fibrinolytic therapy. 
 The result was supported by a study conducted by Alon Marmor, et al.,(2009) from 
MEDLINE databases of prospective studiesLQ$XJXVWDQDO\VLVRIWKHVWXG\VKRZVWKDW
episodes of anginal pain during hospitalization was significantly associated with recurrent MI. 
 
5.2.1 (d)  Rehabilitation programme 
The analysis in the table 4.2.1 (d) shows a significant association between participation in 
UHKDELOLWDWLRQSURJUDPPHDQGUHFXUUHQW0,DWSZLWKFRUUHVSRQGLQJRGG¶VUDWLR0.441. The 
result implies rehabilitation programme is a protective factor  against recurrent MI. 
 
The findings was supported by a study conducted by Harbman .P (2010), to study the 
effect of secondary prevention programmes for coronary artery disease on reduction of recurrent 
MI and mortality using metaanalysis. 63 randomized control trial studies were selected based on 
inclusive criteria. The result showed a significant reduction in recurrent MI and mortality in 
patient who received secondary intervention programmes. 
 
5.2.1 (d) Revascularization procedure 
The analysis in the table 4.2.1 (f) shows a significant association between 
UHYDVFXODUL]DWLRQSURFHGXUHVDQGUHFXUUHQW0,DWSZLWKDFRUUHVSRQGLQJRGG¶VUDWLR
which implies revascularization procedure is a protective factor against recurrent MI. 
 
The mechanism behind this is revascularization procedures has very less possibility for 
reocclusion.                        
 
The findings was supported by a study  conducted by Gregg w. Stone et al.,(2010) to 
examine the  occurrence  of recurrent MI after thrombolysis using randomized control trials. 81 
patients who underwent intracoronary thrombolysis records were reviewed, out of which 36 
patient had recurrent MI. The study suggested the need for a more definitive revascularization 
strategy for acute myocardial infarction. 
 
5.2.1 (f) Location and Type of infarction  
The analysis in the table 4.2.1 (f) shows a significant association between type of 
LQIDUFWLRQDQGUHFXUUHQW0,DWSZLWKFRUUHVSRQGLQJRGG¶VUDWLR7KLVLQGLFDWHVWKDW
patient with NSTEMI is a precipitating factor for recurrent MI. 
The mechanism behind this is patient with NSTEMI have associated co-morbid illness 
and it is due to partial occlusion of major coronary arteries or minor branches of coronary 
arteries. 
 
The analysis in the table 4.2.1 (f) shows a significant association between location of 
LQIDUFWLRQDQGUHFXUUHQW0,DWSZLWKFRUUHVSRQGLQJRGG¶VUDWLR7KLVLPSOLHVSDWLHQW
with nontransmural location is a precipitating factor for recurrent MI. 
 
The findings was supported by a study conducted by Alon Marmor et al., (2009), the 
sample included 350 patients with acute MI, initial 200 patients were considered training set and 
next 100 patients taken for test set. The two sets were compared with 14 clinical characteristics. 
In the training set, the incidence of recurrent infarction was 43% after non-transmural and  8% 
after transmural infarction. Similar values were obtained in the test set in 150 new patients, 
where the incidence of recurrent infarction was 40% after a non transmural infarction, compared 
with only 10% after an initial transmural infarction. 
 
5.2.2 Genetic factors  
5.2.2 (a) Family history of dyslipidemia 
The analysis in the table 4.2.2 (a) depicts a significant association between family history 
of dyslipidemia and recurrent MI at p<0.05. 
 
5.2.3 Life style factors 
5.2.3 (a) Leisure time 
The analysis in the table 4.2.3(b) depicts a significant association between leisure time 
and recurrent MI at p<0.01. 
 
 
5.2.3 (b) Sleep pattern 
The analysis in the table 4.2.3 (a) shows a significant association between sleep pattern 
DQGUHFXUUHQW0,DWSZLWKFRUUHVSRQGLQJRGG¶VUDWLR,WLQGLFDWHVXQLQWHUUXSWHGVOHHS
is a protective factors for recurrent MI. 
The same table depicts significant association between duration of sleep and recurrent MI 
at p<0.01 with corresponding ratio 5.438. It indicates lesser duration of sleep is a precipitating 
factor for recurrent MI 
 
The findings was supported by a study conducted by Leineweber et al., (2009) identified 
the effect of  poor sleep and risk of recurrent events with coronary disease among middle-aged 
women. All women patients under 65 were selected and followed up between 1994 -2000 for 
recurrent events. Quality of sleep, restorative function of sleep, and snoring were assessed by the 
Karolinska Sleep Questionnaire (KSQ). Results indicate that poor sleep and sleep without a 
restorative function are associated with recurrent coronary events. 
 
5.2.3 (c) Duration of smoking 
The analysis in the table 4.2.3(d) shows a significant association between the groups with 
regard to  duration of smoking and recurrent MI with coUUHVSRQGLQJRGG¶V UDWLR LV. This 
indicates patient exposed to lesser duration of smoking are less likely to develop recurrent MI. 
 
The mechanism behind this factor is prolonged exposure increases the risk of 
atherosclerosis in major coronary arteries and its branches. 
 
5.2.3 (d) Habit of exercise and its duration 
The analysis in the table 4.2.3(f) depicts a significant association between exercise 
duration and type of exercise against recurrent MI at p<0.05 between case and control group. 
7KHFRUUHVSRQGLQJRGG¶VUDWLRLVIRUGXUDWLRQRIH[HUFLVHThis indicates patient engaging 
in exercise for more than 15hrs per week are at decreased risk for developing recurrent MI. 
 
5.2.4 Dietary factors 
5.2.4 (a) Intake of Green leafy vegetables 
The analysis in the table 4.2.4(a) shows a significant association with regard to intake of 
greens between case and control group. The odds ratio, 0.075 for the intake of green leafy 
vegetables  indicates it as a protective factor against recurrent MI 
 
5.2.4 (a) Salt intake 
The analysis in the table 4.2.4 (b) depicts a significant association between salt intake and 
recurrent MI at p<0.01 
 
5.2.4 (b) Sugar intake 
The analysis in the table 4.2.4 (b) indicates a significant association between sugar intake 
and recurrent MI at p<0.05 
 
5.2.4 (c) Cooking style 
The analysis in the table 4.2.4(b) depicts a significant association between cooking style 
and recurrent MI at p<0.05 between case and control group.The result indicates that boiling is a 
protective factor for recurrent MI. 
 
Hence RH1 which was stated that there is a significant association of selected factors 
between case and control group was accepted for; 
 Chronicity and treatment for DM 
 Chronicity of HT 
 Episodes of angina pain after thrombolysis 
 Rehabilitation programme 
 Duration of health check ups 
 Family history of dyslipidemia 
 Leisure time/day 
 Sleep pattern and duration of sleep per night 
 Duration of smoking 
 Duration and type of exercise 
 Green leafy vegetables 
 Cooking style 
 Sugar and salt intake  
 Blood pressure 
 Revascularization procedure 
 Type and location of infarction 
and rejected for other factors. 
5.3: The objective of the study was to identify the precipitating factors for recurrent MI 
among the group. 
The precipitating factors which were identified includes 
 
5.3.1 Clinical Prognostic factors 
 Episodes of anginal pain after thrombolysis 
 Blood Pressure 140-159/90-99 
 NSTEMI 
 Non-Transmural infarction 
 Treatment duration for HT>10years 
 %0, 
 Chronicity of HT 
 Central obesity  
 Co-morbidity ± respiratory disease & renal disease 
 Chronicity & treatment duration  of  DM 6-10years 
 Hypertension 
 
5.3.2 Life style factors: 
 Cessation of smoking  less than 36 months 
 'XUDWLRQRIVOHHSKRXUV 
 Working hours (10-15hrs) 
 Duration of smoking >10 years 
 Smoking habit 
 Night shift 
 Alcohol consumption 
 5.3.3 Genetic factors 
 Maternal  & paternal history of dyslipidemia 
 Maternal, Paternal & sibling  history of HT 
 Paternal history of heart disease 
 
 
 
5.3.4 Dietary factors 
 Non ± vegetarians 
 Non-veg foods± chicken, mutton & fish 
 
5.4 The protective factors identified includes, 
 Rehabilitation programme 
 Habit of doing exercise & its duration 
 Intake of green leafy vegetables 
 
Hence the research hypothesis RH2: There are significant precipitating factors for 
recurrent MI among the group was accepted for the above mentioned factors and rejected for 
the others. 
 
 
 
 
 
 
 
 
 
 
  
 
 
CHAPTER 6 
SUMMARY, CONCLUSION, 
IMPLICATIONS, 
RECOMMENDATIONS AND 
LIMITATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY, CONCLUSIONS, IMPLICATIONS, 
RECOMMENDATIONS AND LIMITATIONS 
 
 
6.1 SUMMARY 
Myocardial Infarction is the most common cause of mortality and morbidity which 
accounts for 32% death in India. According to WHO, survivors of MI are at increased risk of 
recurrent infarctions and have an annual death rate of 5%. It is the consequence of large 
population and high prevalence of cardiovascular risk factors. There is a widespread acceptance 
of the benefits of secondary prevention (i.e.) preventing recurrent infarction in patients with 
established MI.  Secondary prevention is positioned at the boundary between prevention and 
treatment. Nurses are more influential among health care team in secondary prevention by 
assessing precipitating factors and educating the MI survivors. 
 
The objectives of the study was 
1. To associate the selected factors such as clinical prognostic factors, genetic factors, life 
style related factors and dietary factors between the case and control group. 
2. To identify the significant precipitating factors for recurrent MI among the group.  
 
The hypotheses formulated were 
RH1:  There is a significant association of selected factors such as clinical prognostic, genetic, 
life style and dietary factors between case and control group.  
RH2: There are significant precipitating factors for recurrent Myocardial Infarction among case 
and control group. 
 
The investigator has strongly rooted the study with extensive review of literature, 
professional experience and proficient guidance from the field of Medical-Surgical Nursing. It 
also provided strong foundation for the study, including integrating  theories into conceptual 
framework, selecting the research design and patients and developing the tool for data collection. 
 
The researcher adopted case control design to identify the precipitating factors for 
recurrent MI among patients attending cardiac OPD  at FLL Hospital, Chennai. %HWW\1HXPDQ¶V
System model was adopted for the conceptual framework, which endowed a comprehensive 
framework for identifying the precipitating factors for recurrent MI.  
 
The content validity for the data collection tool was obtained from an interventional 
cardiologist, intensivist, 3 nursing experts and a biostatistician. The reliability of the tool was 
assessed using inter-rater method and the feasibility was analyzed by conducting a pilot study at 
FLL Hospital for both case and control group. The report obtained from the pilot study supported 
the investigator¶VSODQ to proceed for the main study. 
 
The main study was conducted at Frontier Life Line Hospital, Chennai for both case and 
control group. Non probability purposive sampling technique was used and the sample size was 
117(case -56, control ± 61). The samples were selected based on the inclusion and exclusion 
criteria. Ethical principles were strictly followed throughout the study. 
 
The data collected was analyzed and interpreted using descriptive and inferential 
statistics based on the formulated objectives and hypothesis. The findings revealed that there 
were significant precipitating factors for recurrent MI among the group. 
 
The major findings of the study 
There is a significant association of selected factors between case and control group, they 
were as listed below: 
 Chronicity and treatment for DM 
 Chronicity of HT 
 Episodes of anginal pain after thrombolysis 
 Rehabilitation programme 
 Duration of health check ups 
 Family history of dyslipidemia 
 Leisure time/day 
 Sleep pattern and duration of sleep per night 
 Duration of smoking 
 Duration and type of exercise 
 Green leafy vegetables 
 Cooking style 
 Sugar and salt intake  
 Blood pressure 
 Revascularization procedure 
 Type and location of infarction 
 
The significant precipitating factors identified among the group was: 
5.2.1 Clinical Prognostic factors: 
Episodes of anginal pain after thrombolysis, Blood Pressure 140-159/90-99, NSTEMI, 
Non-transmural infarction, >10 years chronicity & treatment duration for HT, BMI , central 
obesity, respiratory & renal disease as co-morbid illness and 6-10years  chronicity & treatment 
duration  of  DM. 
 
5.2.2 Lifestyle factors: 
Cessation of smoking  less than 36 months, dXUDWLRQRI VOHHSKRXUV, working hours 
(10-15hrs), duration of smoking >10 years, smokers, night shift, alcohol consumption. 
 
5.2.3 Genetic factors 
Maternal & paternal history of dyslipidemia, maternal, paternal & sibling  history of HT 
and paternal history of heart disease. 
5.2.4 Dietary factors 
Non ± vegetarians and type of non-vegetarian foods± chicken, mutton & fish 
 
5.3 The protective factors identified includes, 
Rehabilitation programme, habit of doing exercise & its duration & intake of green leafy 
vegetables. 
 
 
6.2 CONCLUSION 
    The present study aimed at identifying the precipitating factors for recurrent MI. Through this the 
researcher desires to communicate that these precipitating factors should be focused upon in the 
preparation of assessment formats for identifying the risk for recurrent MI. Prioritizing on the control of 
these factors should be a core component of the health education provided to MI affected patients by 
health care providers as an essential step towards secondary prevention of MI. 
6.3 IMPLICATIONS 
The researcher has drawn the following implications from the study, in the field of 
nursing practice, nursing administration, nursing education and nursing research. 
6.3.1 Nursing Practice 
Nurses being a vital part of the health care team, hold responsibility in assessing and 
educating patients for the prevention of recurrent MI. Hence they are in need of knowing the 
precipitating factors in order to reduce the rising burden of recurrent MI. The means are as 
follows, 
 To motivate and/or facilitate engagement of MI patients, who have greater need for risk 
factor modification and support, in cardiac rehabilitation programmes. 
 To initiate and sustain interventions that lower risk of recurrent MI  from the initial phase 
of cardiac rehabilitation. 
 To implement nurse-led short-term secondary prevention programmes against recurrent 
MI. 
 6.3.2 Nursing Education 
 Nursing curriculum should include all the risk assessment strategies related to 
cardiovascular disease along with three modes of preventions. 
 Student nurses should be trained in assessing and educating public regarding risk for  
recurrent MI and its prevention. 
 Nursing students should be encouraged to utilize evidence based guidelines in caring for 
MI patients. 
 Conduct seminars, workshops and conferences for students related to advancement in 
primordial and secondary prevention strategies in order to enhance their knowledge and 
skill in caring patients with MI. 
6.3.3 Nursing Administration. 
 In community effective risk assessment programmes should be conducted for patient with 
incident and recurrent MI. 
 The nurse administrators in the hospital should design a clinical log for all in- patients 
with incident and recurrent MI to enable hospital staff to make entry whenever education 
about secondary prevention of MI is given.. 
 Utilize evidence based guidelines to plan training programmes for both hospital and 
community health personnel. 
 Collaborate with governmental and non-governmental organizations to create policies 
and to conduct awareness programme on secondary prevention of MI. 
6.3.4 Nursing Research 
As a nurse researcher, 
 The identified precipitating factors can be incorporated in framing assessment criteria to 
screen for recurrent MI risk.  
 Standardization of the above specified tool can be done through further research,  
     on larger MI population, to measure the validity and reliability of the tool. 
 
6.4 RECOMMENDATIONS 
The investigator recommends, 
            Communication of the study findings and its significance to hospital authorities to enable 
its incorporation into the assessment and rehabilitation component of MI patients at FLL 
Hospital.  
1. Developing assessment criteria for identifying risk for recurrent MI and utilizing it  in 
hospital and community settings. 
2. Nurse-led short±term secondary prevention programmes with focus on controlling the 
identified precipitating factors can be incorporated  as a component of cardiac 
rehabilitation in hospitals 
3. Utilization of the study  findings in formulating health education sessions for MI patients 
in hospitals and community health centres. 
4. To conduct similar study among rural population and also on  larger groups for greater 
generalization of results. 
 
6.5 LIMITATIONS 
The investigator found difficulty in 
 getting larger samples  
 getting previous records from samples 
 matching variables among groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
BOOKS 
Agarwal, B.L (2011). Textbook of Statistics. New Delhi: CBS publishers and    
distributors. 
Bala.(2007). Fundamentals of Biostatistics. New Delhi: Anne publications. 
Basvanthappa, B.T.(2007). Nursing Research. Bangalore: Jaypee brothers 
Basvanthappa, B.T.(2008). Nursing Research. Bangalore: Jaypee brothers 
Braunwald, Eugene et.al (2006). +DUULVRQ¶V 3ULQFLSOHV RI ,QWHUQDO 0HGLFLQH New 
York:Mc Graw Hill publishers. 
Burns, Nancy. (2009). The practice of nursing research, Missouri: Saunders publications. 
Christensen, Barbara L., & Kockrow, Elaine. (1995). Foundation of Nursing. 
St.Louis:Mosby Company. 
Coachman, Wendy., & Dawson, Jane. (2005). Nursing and Health Care Researc a 
Practical Guide. London: RCN publishing company Ltd. 
Constance, Hieule J., & Craven, Ruth F. (2007). Fundamentals of Nursing: human health 
and function. Philadelphia: Lippincott publishers. 
Denise, Polit F.(2010). Nursing research ± principles and methods. Philadelphia: 
Lippincott Company. 
Edwards, R.W., et al. (1991). Davidson Principles and Practice of Medicine. Hongkong: 
ELBS edition. 
Elakkuvana, Raj Bhaskara. (2010). Nursing research and Biostatistics. Bangalore: 
Emmess publishers. 
Fawcett, Jacqueline. (2005). Analysis and Evaluation of Nursing Theories. Philadelphia: 
F.A Davis company publishers. 
George, Julia B. (1995). Nursing Theories. Philadelphia: Mosby Company 
Geri Le Brindo Wood., & Haber, Judith.(1990). Nursing Research Methods, Critical 
Appraisal and Utilization. Toronto:CV. Mosby company. 
Grove, Susan K., & Burns, Nanct=y. (2005). The Practice of Nursing Research: 
appraisal, synthesis and generation of evidence. USA: Elsevier publishers. 
Gurumani (2005). Introduction to Biostatistics. Bangalore: Jaypee publishers 
Hatchett, Richard., & Thompson, David R(2007) Cardiac Nursing: A Comphrehensive 
Guide. China:Elsevier. 
Ignavaticus, Donna D., & Workman, Linda M. (2013). Medical-Surgical Nursing Patient 
±Centered Collaborative Care. United States Of America:Elsevier. 
James, Fain A.(2009). Reading, Understanding and Applying Nursing Research. New 
Delhi: Jaypee publishers. 
Johnson, Betty M., & Webber, Pamela B. (2005). An Introduction to theory and 
reasoning in nursing. USA: Evolve Elsevier publication. 
Kozier, Barbara., et al.(2000). Fundamentals of nursing concepts and process. New 
York. Addison Wesley publishers. 
Lemone, Priscilla., & Burke, Karen.(2008). Medical Surgical Nursing Critical Thinking 
in Client Care. New Delhi: Dorling Kindersely publishers. 
Lewis Sharon L., et al. (2007). Medical Surgical Nursing ± Assessment and Management 
of Clinical Problems. St.Louis: Mosby Company. 
Mahajan, B.K. (2005). Methods in biostatistics, New Delhi: Jaypee brother publishers 
Mcneill Patrick., & Chapman Steve (2005). Statistical Methods for Health Care 
Research. New York.Lippincott Williams and Wilkins. 
Nicoll, Leslie H. (1992). Perspective of nursing theory. Philadelphia: J.P Lippincott 
publishers. 
Patrick, Joyce Fitz J., et al. (2005) Conceptual models of nursing ± Analysis and 
Application. Marylant: Apprentice Hall publishers. 
Peggy, Chinn L. (2004). 1XUVLQJ5HVHDUFK0HWKRGRORJ\ ,VVXHVDQG ,PSOHPHQWDWLRQ¶V
Aspen publishers. 
Rao sundar.(2006).  Introduction to biostatistics and research method. New delhi: 
Prentice hall of India. 
Satyanarayana.(2006). Biostatistics. New Delhi: Practice Hall of India PVT Limited. 
Shafer, Kathleen Newton., et al. (2008). Medical Surgical Nursing. London: C.V Mosby 
company. 
Suddarth, Doris Smith. (1991). The Lippincott Manual of nursing Practice. Philadelphia: 
J.B. Lippincott Company. 
Veer, Restog Bala (2009). Fundamentals of Biostatistics. New Delhi: Anne Books PVT 
Ltd. 
Treece.(2005). Elements of Research in Nursing. New Delhi: All India Publishers and 
Distributors. 
 
JOURNALS: 
Allen, Jerilyn K., Purcell, Alison., Szanton, Sarah., & Dennison, Cheryl R.(2010). 
Perceptions of Cardiac Risk among a Low-Income Urban Diabetic Population. 
Journal Health care poor Underserved. 1(@1), 362-370. 
Logaraj, M., Balaji,R., John, K.R., Kumar, Shailendra B., & Hegde. (2014). Comapritive 
study on Risk Factors for Cardiovascular diseases between Urban and Rural 
Population In Tamil Nadu. National Journal Of Research In Community Medicine. 
(3)2, 103-112. 
 
ONLINE JOURNALS: 
Pantaleo Giannuzzi. et al (2008). Global secondary prevention strategies to limit  
        event  recurrence after MI . Journal of American Medical Association.   
       168(20)  2194-2204. Available from: 
       http;//www.archinte.jamanetwork.com/article.aspx.articleid=414622/ 
Krishnaraj.S.Rathod., Shoaib Siddique., Barron Gin., John Hogan and Sandy  
       Gupta. (2012). Secondary prevention programme for Myocardial Infarction.  
      British Journal of Cardiology. 19(1) 167-169. Available from: 
        http://www.bjcardio.co.uk/2012/11/secondary prevention regimen/ 
Cooper et al. (2009). Clinical guidelines and evidence ± review of post MI. Royal  
      college of general practitioners.1-9 Available from: 
       http://www.ncgc.ac.uk/guidelines/NTA-MI%20 secondary%20prevention.pdf/ 
Rafael et al. (2014). Vital exhaustion and anxiety are related to subjective quality  
     of life in patients with AMI. Journal of clinical nursing.23(19/20) 2864-2873.     
     Available from: 
      http://www.ncbi.nlm.gov/pubmed/25280137/ 
Van Der Elst et al. (2009). Effect of drug combination on admission for recurrent  
      MI. American Journal Of Critical care. 93(10) 1226-1230. Available from: 
        http://www.ncbi.nlm.nih.gov/pmc/articles/PMC 20009577/. 
Chvun .D. (2012). Cardiac outcomes after MI in patient with DM. American   
      Journal of Critical Care. 11(6) 504-519. Available from: 
       http://www.ncbi.nlm.nih.gov/pm/articles/PMC 2571066/. 
Chamosa Saioa. et al. (2015). Predictors of enrollment in cardiac rehabilitation  
       programme. Journal of Cardiopulmonary Rehabilitation and prevention.   
      35(4) 255-262. Available from: 
       http://www.journals/ww.com/jcrjournal/fulltext/ 
Harbman P. (2009). Secondary prevention programmes with and without exercise  
       reduced all cause mortality and recurrent MI.  Evidence based nursing. 9(3)  
      77. Available from: 
       http://www.ebn.bmj.com/content/9/3/77. extract/. 
Mclark A.M. (2015). Secondary prevention programme for patients with CAD.  
       Annals of Internal Medicine. 143(9) 659-667. Available from: 
       http://www.revespcardiol.org/en/improving-quality-of-care/article. 
Vandermeer B.(2010). Risk of all-cause mortality, recurrentMI & heart failure  
      associated with smoking status following MI. American Journal of  
      Cardiology. 106(7) 911-916. Available from: 
      http://www.ncbi.nlm.nih.gov/pubmed/20854949/. 
Leineweber .C et al.(2012). Poor sleep increases the prospective risk for recurrent  
      events.Journal of Psychosomatic research. 54(2) 121-127. Available from: 
       http://www.ncbi.nlm.nih.gov/pubmed/12573733/. 
Giplin. F. (2009). Trends in AMI event rates & risk of recurrence after an incident  
      event. American Journal of Cardiology. 121(2 pt 1) 451-65. Available from: 
       http://www.ncbi.nlm.nih.gov/pubmed/12381077/. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX - C 
/(77(56((.,1*(;3(57¶623,1,21)25 CONTENT VALIDITY 
 
From, 
Mrs.S.Pichammal 
M.sc(N) I year, 
Omayal Achi College of Nursing, 
Puzhal, Chennai 
 
To, 
 
Respected Sir/Madam, 
                                  Sub: Requisition for expert opinion for content validity. 
              I, Mrs.S.Pichammal, am doing my M.Sc Nursing, specializing in Medical Surgical 
Nursing at Omayal Achi College of Nursing during May 2014-2016, under the guidance of 
Dr.Mrs.Kanchana, Principal and Research Director, ICCR and speciality guide Mrs.Jose Eapen 
Jolly Cecily. As a part of my research project to be submitted to the Tamil Nadu Dr. M.G.R. 
Medical University, Guindy, Chennai, in partial fulfillment of the requirement for the award of 
M.Sc(N) degree, I have proposed to conduct a ³$ &DVH FRQWURO VWXG\ WR LGHQWLI\ WKH
SUHFLSLWDWLQJIDFWRUVIRU5HFXUUHQW0\RFDUGLDO,QIDUFWLRQDWVHOHFWHGVHWWLQJV&KHQQDL´ 
             I have enclosed my data collection tool for your expert guidance and validation. Kindly 
do the needful. 
                                                              Thanking You,                     
                                                                                                              Yours faithfully,                        
(S.PICHAMMAl) 
ENCLOSURES: 
1. Content validity requisition form 
2. Research proposal 
3. Data collection tool 
4. Certificate for content validity                      
 
 
LIST OF EXPERTS FOR CONTENT VALIDITY 
 
MEDICAL EXPERT 
1. Dr. Joy Thomas 
Consultant cardiologist, 
Frontier Life Line Hospital, 
Mogaippair, Chennai 
Tamil Nadu. 
 
2. Dr. P.Ramamoorthy 
Consultant Cardiologist, 
Sir Ivan Stedford hospital, 
Ambattur, Chennai. 
Tamil Nadu. 
 
MEDICAL SURGICAL NURSING EXPERT 
3. Mr. Gopichandran 
Lecturer, 
All India Institute of Medical Science, 
New Delhi. 
 
4. Prof.(Mrs). Malarvizhi 
Vice Dean 
Pondicherry Institute of Medical Science, 
Pondicherry. 
 
5. Mrs. Chandralekha 
Associate Professor 
Indirani College of Nursing 
Sri Venkateshwara Medical College, 
Ariyur, Pondicherry. 
  
 
 
 
CERTIFICATE FOR CONTENT VALIDITY 
 
 
           This  is  to  certify  that  the  data  collection tool  developed  by  Mrs.S.Pichammal, 
M.Sc (Nursing) I year student (May 2014-2016) of  Omayal Achi College of Nursing, as part of 
the research project, ³$ &DVH FRQWURO VWXG\ WR LGHQWLI\ WKH SUHFLSLWDWLQJ IDFWRUV IRU
Recurrent Myocardial Infarction at selecWHGVHWWLQJ&KHQQDL´ to be submitted to the Tamil 
Nadu Dr. M.G.R. Medical University, Guindy, Chennai, in partial fulfillment of the requirement 
for the award of M.Sc(N) degree,  is validated by the undersigned and she can proceed with this 
tool to conduct the main study. 
 
 
 
 
Signature with date: 
 
Seal: 
 
 
 
 
 
 
 
 
 
 
APPENDIX ± D 
 
CERTIFICATE FOR ENGLISH EDITING 
 
 
 
TO WHOMSOEVER IT MAY CONCERN 
 
     This is to certify that the dissertation work ³$ &DVH FRQWURO VWXG\ WR LGHQWLI\ WKH
precipitating factors for 5HFXUUHQW 0\RFDUGLDO ,QIDUFWLRQ DW VHOHFWHG VHWWLQJ &KHQQDL´ 
prepared by Mrs. S.Pichammal, M.Sc Nursing II year student of Omayal Achi College of 
Nursing, Chennai, under the guidance of Prof.(Mrs).Jose Eapen Jolly Cecily has been edited for 
English language appropriateness by _____________________________________________. 
 
Signature with Date: 
 
 
 
Seal: 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX ± E 
INFORMED CONSENT REQUISITION FORM 
 
Good morning, 
      I Mrs. S.Pichammal., M.Sc.(Nursing) II year student from Omayal Achi College Of 
1XUVLQJ &KHQQDL FRQGXFWLQJ  ³$ &DVH &RQWURO VWXG\ WR LGHQWLI\ WKH SUHFLSLWDWLQJ IDFWRU IRU
UHFXUUHQW P\RFDUGLDO LQIDUFWLRQ DW VHOHFWHG VHWWLQJ &KHQQDL´ DV D SDUWLDO IXOILOOPHQW RI WKH
requirement for the degree of M.Sc. Nursing under the Tamil Nadu Dr. M.G.R  Medical 
University. 
 
  I assure you that information provided by you will be kept confidential. Hence I request 
you to kindly cooperate with me and participate in this study by giving your frank and honest 
responses to the questions being asked. 
Thank you 
 
   Signature of the investigator 
                             Mrs. S.Pichammal 
  
INFORMED CONSENT FORM 
 
           I understand that I am being asked to participate in a research study conducted by 
Ms.S.Pichammal., M.Sc(Nursing) student from Omayal Achi College of Nursing, Puzhal, 
&KHQQDL 7KLV UHVHDUFK VWXG\ ZLOO LGHQWLI\ ³Precipitating factors of Recurrent Myocardial 
,QIDUFWLRQDW VHOHFWHGVHWWLQJ&KHQQDL´ If I agree to participate in the study, I will be asked 
series of questions by structured interview schedule to know the demographic variable and to 
identify the precipitating factors.  The answers will be kept confidential. No identifying 
information will be included during the analysis process. I understand that there are no risk 
associated with this study. 
 
          I realize that I will be benefited by this study. I recognize that my participation in this 
study is entirely voluntary and I may withdraw from the study at any time I wish. If I decide to 
discontinue my participation in this study, I will be continued to be treated in the usual and 
customary fashion. 
 
          I understand that all study details will be kept confidential. However, this information may 
be used in nursing publication or presentations. If I need to, I can contact Ms.S.Pichammal, 
M.Sc Nursing student from Omayal Achi College of Nursing, Puzhal, Chennai-66. Phone No: 
04426591617 at any time during the study. The study has been explained to me, I have read and 
understood the consent form, my entire doubts have been answered, and I agree to participate. I 
understand that I will be given a copy of this signed consent form.                                                                           
 
 
 
 
Signature of the Participant                                                       Date                                             
------------------------------------                                                    --------                                                                      
Signature of the Research Investigator                                       Date   
 
 
 APPENDIX - F 
 
 
PART A: Demographic Variables: 
1. Age in years 
 
2. Gender 
a. Male 
b. Female 
 
3. Education  
a. Non-literate 
b. Primary 
c. Higher secondary 
d. Degree 
e. Others 
 
4. Occupation  
a. Skilled 
b. Technical 
c. Professional 
d. Business 
e. Home maker 
f. Others 
 
5. Family Monthly Income 
a.  
b. 5001 ± 10,000  
c. 10,001 ± 15,000 
d. ,000 
  
 
6. Marital Status 
a. Single 
b. Married 
c. Widow/Widower 
d. Separate 
e. Divorce 
f. Others  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART B 
I. Clinical Prognostic Factor: 
7. Episodes of Anginal pain during hospitalization (after thrombolysis.) 
a. No episode 
b. 1 episode 
c. 2 episodes 
d. HSLVRGH 
e. NA 
 
8. Are you a diabetic? 
a. Yes 
b. No 
 
If yes 
9.  Chronicity of Diabetes Mellitus? 
a. <12months 
b. 1-5 years 
c. 6-10 years 
d. >10years 
e. NA 
 
10.  Treatment duration  
a. <12months 
b. 1-5 years 
c. 6-10years 
d. 10years 
e. NA 
 
11.  Are you a hypertensive? 
a. Yes 
b. No 
  
 
If yes 
12.  Chronicity of hypertension 
a. <12months 
b. 1-5years 
c. 6-10years 
d. >10years 
e. NA 
 
13.  Treatment duration 
a. <12months 
b. 1-5 years 
c. 6-10years 
d. 10years 
e. NA 
14. Adherence to drug therapy 
a. Regular 
b. Irregular 
c. Discontinued  
 
If irregular or Discontinued 
15.  Reason for drug non-compliance 
a. Expensive 
b. Alternative medical treatment 
c. side effect 
d. Others (specify) 
e. NA 
 
16.  Participated in Rehabilitation Programme 
a. Yes 
b. No 
 
17.  Health check ups 
a. Regular  
b. Irregular 
c. Others (specify) 
18. Duration of Health check ups 
a. Monthly once 
b. Every 3 months 
c. Every 6 months 
d. Yearly once 
 
II. Genetic factors: 
19.  Family history of heart disease 
a. Paternal  
b. Maternal  
c. Both  
d. Sibling  
e. More than one  
f. Nil 
 
20. Family history of Hypertension 
a. Paternal  
b. Maternal  
c. Both  
d. Siblings 
e. More than one 
f. Nil 
  
21.  Family history of Diabetes Mellitus 
a. Paternal  
b. Maternal 
c. Both 
d. Siblings 
e. More than one 
f. Nil 
 
22. Family history of Dyslipidemia 
a. Paternal  
b. Maternal 
c. Both  
d. Siblings 
e. More than one  
f. nil 
 
III. Lifestyle factors: 
23. Duration of working hour/day 
a. KUV 
b. 5-10 hours 
c. 10-15hours 
d. KRXUV 
e. NA 
 
24. Do you work in night shift? 
a. Yes 
b. No 
 
If yes 
25. How many weeks per month? 
a. <2 week 
b. > 2 week 
c. NA 
 26.  Time spent for leisure activities/week. 
a. Nil 
b. <5 hours 
c. <10hours 
d. <15hours 
e. >15hours 
 
27. Sleep pattern 
a. Uninterrupted  sleep 
b. Interrupted sleep 
 
28. Duration of sleep at night 
a. KRXUV 
b. 6-10 hours 
c. >10hours 
 
29.  Are you a smoker? 
a. Yes 
b. No 
 
30.  Current smoking status 
a. Active smoker 
b. Former smoker 
c. Quitter(after incident MI) 
d. NA 
 
31.  Duration of smoking. 
a. <3 years 
b. 4-6 years 
c. 6-8 years 
d. >9years 
e. NA 
 
32.  Duration of cessation 
a. 0 to <6months 
b. 6 to <18months 
c. 18 to <36months 
d. 36 to <48months 
e. 48 to 60 months 
f. NA  
 
33. Number of cigarettes per day 
a. <2 
b. 3-5 
c. >6 
d. NA 
34. Are you an alcoholic? 
a. Yes 
b. No 
 
35. Type of drinker 
a. Regular 
b. Weekly 
c. Social occasions  
d. NA 
 
36. Type of alcohol 
a. Wine 
b. Liquor 
c. Beer 
d. Others 
e. NA 
 37. How many types of alcohol do you take/day? 
a. 1 
b. 2 
c.  
d. NA 
 
38.  Amount of alcohol/day 
a. PO 
b. 180 ± 260ml 
c. PO 
d. NA 
 
39. Do you have the habit of doing exercise? 
a. Yes 
b. No 
 
 
If yes 
40. Duration per week 
a. KRXUV 
b. 8 ± 14 hours 
c. KRXUV 
d. NA 
 
41.  Types of exercise 
a. Walking 
b. Jogging 
c. Aerobics  
d. Yoga  
e. NA 
 IV. Dietary factors: 
42.  Are you a 
a. Vegetarian 
b. Non-vegetarian 
c. Ova vegetarian 
 
43. Frequency of Non vegetarian foods consumption  
a. Once a week 
b. Twice a week 
c. Thrice a week 
d. >4 times 
e. NA 
 
44. Consumption of salt(tsp/day) 
a.  
b. 2 
c. 3 
d.  
 
 
45. Consumption of sugar(tsp/day) 
a.  
b. 2 
c. 3 
d.  
 
46. Type of red meat  
a. Chicken 
b. Mutton 
c. Beef  
d. Pork 
e. More than one  
f. others  
g. NA 
 
47. Consumption of green leafy vegetables 
a. Once a week 
b. Twice a week 
c. Thrice a week 
d. More than three times a week 
e. Daily  
 
48.  Consumption of fruits 
a. Once a week 
b. Twice a week 
c. Thrice a week 
d. More than three times a week 
e. Daily  
 
49. Frequency of Preserved foods consumption 
a. Daily 
b. >thrice a week 
c. Twice a week 
d. Once a week 
e. Rare 
50. Cooking style of foods 
a. Boiling 
b. Deep frying 
  
51.  Consumptions of fried foods 
a. Once a week 
b. Twice a week 
c. Thrice a week 
d. More than thrice a week 
 
V. Bio-physiological measures: 
52.  Body Mass Index = weight (kgs) 
                                   height in (m2  ) 
 
Height -  
Weight  -  
a.  
b. 18.5 ± 24.9 
c. 25-29.9 
d.  
 
53. Central obesity =     waist circumference (cm) 
                                 Hip Circumference (cm) 
Male:  
a. 0.95 or below 
b. 0.96 to 1 
c. 1.0+          
 
Female: 
a. 0.80 or below 
b. 0.81 to 0.85 
c. 0.85+ 
 
 
54. Blood pressure 
a. SBP 100-140mmHg & DBP:60-90mmHg 
b. SBP 140-159mmHg & DBP:90-99mmHg 
c. 6%3PP+*	'%3PP+J 
 VI. Record reviews 
55.  Any revascularization procedure done? 
a. Yes 
b. No 
 
56. If yes 
a. Percutaneous Coronary Angioplasty 
b. Coronary Artery Bypass Grafting 
c. Both  
d. NA 
 
57. Type of Infarction 
a. STEMI ± ST elevation Myocardial Infarction 
b. NSTEMI ± non ST elevation Myocardial Infarction 
 
58. Location of Infarction 
a. Transmural 
b. Non- Transmural 
 
59. Type of management for Diabetes Mellitus 
a. Oral hypoglycemic control 
b. Insulin  
c. Both 
d. Alternative medicine 
e. NA 
 
60. Type of management 
a. Calcium channel blockers 
b. Beta blockers 
c. Both 
d. Alternative medicine 
 
61. Past history of 
a. Cerebrovascular accident 
b. Autoimmune disorder 
c. Heart disease 
 
62. Autoimmune disorder  
a. Rheumatoid arthritis 
b. Systemic Lupus Erythematous 
c. Systemic Sclerosis 
d. NA 
 
63. Heart disease  
a. Rheumatic heart disease 
b. Valvular disorders 
c. Others  
 
64. Type of drug management for Hypertension 
a. B-Blockers 
b. ACE inhibitors 
c. Antiplatelets 
d. Others 
e. NA 
 
65. Any other Co-Morbid illness  
a. Respiratory disease 
b. Renal problems 
c. Vascular disease 
 
66. Respiratory Disease 
a. Asthma  
b. COPD 
c. Sleep Apnea 
d. Others 
 
67. Renal Problems 
a. Renal calculi 
b. Infections 
c. Others 
 
68. Vascular Disease 
a. Deep Vein Thrombosis 
b. Varicose Vein 
c. Bleeding Disorders 
d. Others. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 APPENDIX ± H 
BLUE PRINT 
 
S.No Content Item Total Item 
Percentage 
% 
1. Demographic Variables 1-6 6  
2. 
Clinical Prognostic factor 
i. Diabetes Mellitus 
ii. Hypertension  
iii. Drug compliance 
iv. Health check ups 
v. Rehabilitation programme 
 
1-4 
1-3 
1-2 
1-2 
1 
12 19.05 
3 Genetic factors 1-4 4 6.35 
4 
Life style factors 
i. Working hours 
ii. Sleep patten 
iii. Smoker 
iv. Alcohol 
v. Exercise  
 
1-4 
1-2 
1-5 
1-5 
1-3 
19 30.16 
5 Dietary factors 1-10 10 15.88 
6 Bio-physiological measures 1-3 3 4.76 
7 Record reviews 1-15 15 23.8 
 TOTAL 63 63 100 
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